angiotensin ii has been researched along with ng-nitroarginine methyl ester in 465 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 156 (33.55) | 18.2507 |
2000's | 200 (43.01) | 29.6817 |
2010's | 97 (20.86) | 24.3611 |
2020's | 12 (2.58) | 2.80 |
Authors | Studies |
---|---|
Beierwaltes, WH; Carretero, OA; Sigmon, DH | 1 |
Clark, KL; Drew, GM; Robertson, MJ | 1 |
Altavilla, D; Calapai, G; Campo, GM; Caputi, AP; Cilia, M; Squadrito, F; Zingarelli, B | 1 |
Bennett, T; Compton, AM; Foulkes, R; Gardiner, SM; Hughes, B; Kemp, PA | 1 |
Abe, K; Arima, S; Ito, S; Omata, K; Takeuchi, K | 1 |
Granger, JP; Schnackenberg, CG; Wilkins, FC | 1 |
Abdelrahman, A; Pang, CC; Wang, YX | 1 |
Buckalew, VM; Handa, RK; Strandhoy, JW | 1 |
Herizi, A; Jover, B; Mimran, A | 1 |
Bains, JS; Ferguson, AV | 1 |
Jover, B; Mimran, A; Nafrialdi, N | 1 |
Näveri, L; Saavedra, JM; Strömberg, C | 1 |
Hartman, JC | 1 |
Baylis, C; Engels, K; Harton, P; Losonczy, G; Masilamani, S; Samsell, L | 1 |
González, JD; Llinás, MT; Salazar, FJ | 1 |
Campbell, SE; Ganjam, VK; Katwa, LC; Ou, R; Reddy, HK; Sigusch, HH; Weber, KT | 1 |
Brecher, P; Chobanian, AV; Cohen, RA; Hou, J; Kato, H | 1 |
Hintze, TH; Nasjletti, A; Seyedi, N; Xu, X | 1 |
Garrison, EA; Kadowitz, PJ; Osei, SY; Santiago, JA | 1 |
Dick, LB; Miller, KB; Nasjletti, A; Pucci, ML; Smith, CJ | 1 |
Hamann, M; Hegyi, I; Kaissling, B; Kurtz, A; Schricker, K | 1 |
Ahima, RS; Kadowitz, PJ; Khosla, MC; Minkes, RK; Osei, SY; Weaver, JP | 1 |
Carretero, OA; Farhy, RD; Ho, KL; Scicli, AG | 1 |
Cowles, VE; Otterson, MF; Ryan, RP; Sarna, SK | 1 |
Mattana, J; Singhal, PC | 1 |
Bennett, T; Gardiner, SM; Kemp, PA; March, JE | 2 |
Freeman, RH; Simmons, JC | 1 |
Chaudhuri, G; Cuevas, J; Nathan, L | 1 |
Alberola, AM; Granger, JP; Nakamura, T; Salazar, FJ | 1 |
Pfaffendorf, M; Van Meel, JC; Van Zwieten, PA; Zhang, J | 1 |
Bennett, T; Gardiner, SM; Kemp, PA; March, JE; Rakhit, T | 1 |
Baylis, C; Engels, K; Harvey, J | 1 |
Beierwaltes, WH; Newman, JM; Sigmon, DH | 1 |
Bennett, T; Gardiner, SM; Kemp, PA; March, JE; Rubin, PC | 1 |
Atkinson, J; Thorin, E | 1 |
Anderson, S; Houghton, DC; Tank, JE; Vora, JP | 1 |
Chiyotani, A; Isono, K; Konno, K; Sugimoto, F; Tagaya, E; Tamaoki, J | 1 |
Bernheim, J; Feldman, V; Gonen, O; Podjarny, E; Pomeranz, A; Rathaus, M | 1 |
Arbuthnott, GW; Kelly, PA; Ritchie, IM; Thomas, CL | 1 |
Fujioka, H; Fujita, Y; Matsuo, H; Sumikura, T; Syoji, T; Takahashi, N; Uchida, K; Yuasa, S | 1 |
Arima, S; Carretero, OA; Ito, S; Juncos, LA; Ren, Y | 1 |
Baylis, C; Engels, K; Qiu, C | 1 |
Bouskela, E; Hardebo, JE; Morita-Tsuzuki, Y | 1 |
Barrett, RJ; Droppleman, DA | 1 |
Beierwaltes, WH; Sigmon, DH | 2 |
Bennett, T; Gardiner, SM; Kemp, PA; Rubin, PC | 1 |
Baylis, C; Engels, K; Harton, P; Samsell, L | 1 |
Arima, S; Carretero, OA; Ito, S; Juncos, LA; Ren, YL | 1 |
Hasegawa, K; Khosla, MC; Nishimura, H | 1 |
Dupont, M; Herizi, A; Jover, B; Mimran, A; Ventre, F | 1 |
Granger, JP; Hu, L; Manning, RD; Mizelle, HL | 1 |
Cachofeiro, V; Guan, H; Kaminski, PM; Nasjletti, A; Pucci, ML; Wolin, MS | 1 |
Deng, X; Welch, WJ; Wilcox, CS | 1 |
Hashimoto, S; Kawata, T; Koike, T | 1 |
Campbell, SE; Sigusch, HH; Weber, KT | 1 |
Hanamori, T; Iki, K; Ishizuka, Y; Kannan, H; Kunitake, T; Saita, M; Shimokawa, A | 1 |
Brecher, P; Chobanian, AV; Hou, J; Kato, H | 1 |
Duggan, KA; Macdonald, GJ; Yang, Y | 2 |
Melo, LG; Sonnenberg, H | 1 |
Fink, GD; Melaragno, MG | 1 |
Adachi, Y; Hashimoto, K; Hisa, H; Satoh, S; Suzuki-Kusaba, M; Yoshida, M | 1 |
Frank, DU; Johns, RA; Rich, GF; Roos, CM; Xue, C | 1 |
Fujiwara, H; Hirata, K; Kanazawa, H; Kurihara, N; Takeda, T | 1 |
Hisa, H; Kikukawa, M; Satoh, S; Yoshida, M | 1 |
de Nucci, G; Fujihara, CK; Mattar, AL; Ribeiro, MO; Zatz, R | 1 |
Calapai, G; Caputi, AP | 1 |
Cachofeiro, V; Lahera, V; Maeso, R; Muñoz-Garcia, R | 1 |
Cox, SL; Story, DF; Ziogas, J | 1 |
Granger, JP; Solhaug, MJ; Wallace, MR | 1 |
Blanc, J; Elghozi, JL; Gaudet, E; Gouédard, O; Ponchon, P | 1 |
Balazy, M; Falck, JR; Lu, M; Reddy, KM; Wang, W; Zhu, Y | 1 |
Caffarri, G; Capretti, L; Chiodera, P; Coiro, V; Gatti, C; Vescovi, PP; Volpi, R | 1 |
Campese, VM; Nosrati, S; Ye, S | 1 |
Granger, J; Pigg, K; Schnackenberg, C; Tucker, B | 1 |
Fujimura, S; Iwabuchi, S; Koike, K; Ono, S; Tanita, T | 1 |
Fujita, H; Itoh, H; Nakagawa, M; Nakamura, K; Nakata, T; Sasaki, S; Takeda, K; Takenaka, K; Uchida, A | 1 |
Hamaguchi, A; Iwao, H; Kim, S; Ohta, K; Takaori, K; Yagi, K | 1 |
Dewhurst, M; Stevens, EJ; Tomlinson, DR | 1 |
Ahokas, RA; Friedman, SA; Lubarsky, SL; Sibai, BM | 1 |
Beilin, LJ; Chu, ZM | 1 |
Granger, JP; Schnackenberg, CG | 1 |
Adler-Graschinsky, E; Gironacci, MM; Lorenzo, PS | 1 |
Lee, BH; Shin, HS | 1 |
Pinto, A; Sorrentino, R | 1 |
Cachofeiro, V; Lahera, V; Maeso, R; Muñoz-García, R; Navarro-Cid, J; Rodrigo, E; Ruilope, LM | 2 |
Carey, RM; Siragy, HM | 1 |
Champion, HC; Kadowitz, PJ | 1 |
Abe, K; Carretero, OA; Ito, S | 1 |
Comiter, CV; Kifor, I; Sullivan, MP; Yalla, SV | 1 |
Dall'Aglio, P; Fasoli, E; Giberti, D; Montanari, A; Novarini, A; Perinotto, P; Tateo, E | 1 |
Bumgarner, L; Cockrell, K; Granger, JP; Kassab, S; Novak, J; Reckelhoff, J | 1 |
Baigorria, S; Cornejo, JC; Gomes, J; Juncos, LA; Juncos, LI | 1 |
Holmes, EP; Moore, RM; Sedrish, SA; Venugopalan, CS | 1 |
Hutri-Kähönen, N; Kähönen, M; Mäkynen, H; Pörsti, I; Tolvanen, JP; Wu, X | 1 |
de Gasparo, M; Fenoy, FJ; García-Salom, M; Madrid, MI; Tornel, J | 2 |
Geisert, J; Helwig, JJ; Judes, C; Massfelder, T; Muller, C; Simeoni, U; Zhu, B | 1 |
Anania, V; Demontis, MP; Dessì-Fulgheri, P; Emanueli, C; Glorioso, N; Madeddu, P; Palomba, D; Sarzani, R; Varoni, MV | 1 |
Heinemann, A; Holzer, P; Peskar, BA; Wachter, CH | 1 |
Barthelmebs, M; Endlich, K; Helwig, JJ; Muller, C | 2 |
Cowley, AW; Wu, F; Zou, AP | 1 |
Gohlke, P; Pees, C; Unger, T | 2 |
Imdad, RY; Kim, Y; Lonigro, AJ; Sprague, RS; Stephenson, AH | 1 |
Arnal, JF; Michel, JB; Pueyo, ME; Rami, J | 1 |
Liu, JL; Murakami, H; Zucker, IH | 1 |
Bennet, L; Green, LR; Hanson, MA; McGarrigle, HH | 1 |
Adachi, Y; Hashimoto, K; Hisa, H; Ono, N; Satoh, S; Suzuki-Kusaba, M; Yoshida, M | 1 |
Andoh, TF; Bennett, WM; Couser, WG; Johnson, RJ; Pichler, RH; Shankland, SJ; Thomas, SE | 1 |
Carbonell, LF; Delgado, JL; Hernández, I; Pérez, MC; Quesada, T | 1 |
Atucha, NM; Fortepiani, LA; García-Estañ, J; Ortíz, MC; Ruiz-Marcos, FM | 1 |
d'Uscio, LV; Lüscher, TF; Moreau, P; Takase, H | 1 |
Hagiwara, Y; Hanada, M; Kambe, T; Kubo, T; Saito, E | 1 |
Beierwaltes, WH; Brand, PH; Britton, SL; DiPaola, NR; Metting, PJ; Rapp, JP | 1 |
Harding, JW; Kramár, EA; Krishnan, R; Wright, JW | 1 |
Clark, KL; Clayton, JS; Drew, GM; Johns, EJ | 1 |
Braam, B; Koomans, HA; Turkstra, E | 1 |
Endlich, K; Helwig, JJ; Muller, C | 1 |
Henrion, D; Luvarà, G; Mandet, C; Michel, JB; Philippe, M; Pueyo, ME; Savoie, F | 1 |
Abe, I; Fujishima, M; Kagiyama, S; Liu, Y; Matsumura, K; Tsuchihashi, T | 1 |
Cohen, EP; Fish, BL; Moulder, JE | 1 |
Frank, DU; Horstman, DJ; Rich, GF | 1 |
Block, ER; Gelband, CH; Li, YD; Martens, JR; Patel, JM; Raizada, MK | 1 |
Hirata, K; Kanazawa, H; Yoshikawa, J | 1 |
Chodobski, A; Johanson, CE; Szmydynger-Chodobska, J | 1 |
Demeilliers, B; Jover, B; Mimran, A | 1 |
Hamada, K; Hara, N; Nagai, Y; Nakamura, K; Nakanishi, K | 1 |
Carey, RM; Guerrant, RL; Jin, XH; Siragy, HM | 1 |
Cardinal, R; de Champlain, J; K-Laflamme, A; Oster, L | 1 |
Cowley, AW; Maeda, CY; Szentiványi, M | 1 |
Conrad, KP; Danielson, LA; Sherwood, OD | 1 |
Baan, J; Chang, PC; Pfaffendorf, M; van Zwieten, PA; Vermeij, P | 1 |
Block, ER; Hill-Kapturczak, N; Kapturczak, MH; Madsen, KM; Malinski, T; Patel, JM; Tisher, CC | 1 |
Alvis, AG; Grassi de Gende, AO; Milesi, V; Rebolledo, A; Rinaldi, GJ | 1 |
Arnet, UA; Barton, M; Ganten, D; Lüscher, TF; Noll, G; Novosel, D | 1 |
Carbonell, LF; Fenoy, FJ; Hernández, I; Quesada, T | 1 |
Hageman, KS; Musch, TI; Stebbins, CL; Symons, JD | 1 |
Musch, TI; Stebbins, CL; Symons, JD | 1 |
Belayet, HM; Kanayama, N; Khatun, S; Kobayashi, T; Sato, E; Terao, T; Tokunaga, N | 1 |
González, JD; Llinás, MT; Nava, E; Salazar, FJ | 1 |
Fujiyama, A; Fujiyama, S; Iwasaka, T; Kawada, N; Koyama, Y; Kurihara, H; Masaki, H; Matsubara, H; Miwa, T; Miyazaki, M; Mori, Y; Murasawa, S; Nakagawa, K; Nozawa, Y; Ozono, R; Shibasaki, Y; Takahashi, H; Takai, S; Tanaka, Y; Tsutsumi, Y | 1 |
Bayram, M; Ercan, ZS; Keskil, Z; Türker, RK | 1 |
Holm, P; Hutri-Kähönen, N; Jolma, P; Kähönen, M; Kalliovalkama, J; Pörsti, I; Tolvanen, JP; Wu, X | 1 |
D'Amours, M; Grose, JH; Larivière, R; Lebel, M | 1 |
Camargo, LA; Pereira, AF; Saad, R; Saad, WA; Simões, S | 1 |
Berthold, H; Ehmke, H; Just, A; Kirchheim, HR | 1 |
Hata, Y; Kawazoe, T; Kosaka, H; Yoneyama, H | 1 |
Mujumdar, VS; Smiley, LM; Tyagi, SC | 1 |
Heinemann, A; Horina, G; Pieber, D; Pieber, TR; Sandner-Kiesling, A | 1 |
Engler, MB; Engler, MM; Ma, YH | 1 |
Egashira, K; Katoh, M; Koyanagi, M; Matsushima, K; Shimokawa, H; Takeshita, A; Takeya, M; Tomita, H; Usui, M; Yoshimura, T | 1 |
Abernethy, DR; Andrawis, N; Jones, DS | 1 |
Freeman, GL; Murray, DR; Prabhu, SD | 1 |
Arima, S; Endo, Y; Ito, O; Ito, S; Kohagura, K; Omata, K | 1 |
Hayden, MR; Mujumdar, VS; Tyagi, SC | 1 |
Chao, CR; El-Haddad, MA; Ma, Sx; Ross, MG | 1 |
Dworkin, LD; Feiner, HD; Tolbert, EM; Weisstuch, J | 1 |
Datté, JY; Gohlke, P; Pees, C; Ziegler, A | 1 |
Arroyo, V; Bataller, R; Bosch, J; Garcia-Ramallo, E; Gasull, X; Ginès, P; Görbig, MN; Nicolás, JM; Rodés, J | 1 |
Ercan, ZS; Sipahi, EY; Türker, RK | 1 |
Laverty, R; Ledingham, JM | 1 |
Abe, I; Fujishima, M; Kagiyama, S; Lin, Y; Matsumura, K; Tsuchihashi, T | 1 |
Schiffrin, EL | 1 |
Bui, V; Kadekaro, M; Liu, H; Summy-Long, JY; Terrell, ML | 2 |
Howard, EF; Landon, EJ; Myers, PR; Steimle, A; Takagi, T; Tamura, M; Tanner, M | 1 |
Manucha, WA; Valles, PG | 1 |
Adler, GK; Kifor, I; Ochoa-Maya, MR; Rennke, HG; Rocha, R; Stier, CT; Williams, GH | 1 |
Block, ER; Chen, S; Patel, JM | 1 |
Egashira, K; Kataoka, C; Kitamoto, S; Koyanagi, M; Takemoto, M; Takeshita, A; Usui, M | 1 |
Artuso, A; Bouriquet, N; Casellas, D; Moore, LC; Walcott, B | 1 |
Pallone, TL; Silldorff, EP | 1 |
Alonso, MJ; Balfagón, G; Ferrer, M; Marín, J; Salaices, M | 1 |
Barthélemy, C; Carayon, A; Eurin, J; Masson, F; Soualmia, H | 1 |
Barker, LA; Rossoni, LV; Vassallo, DV | 1 |
Dukacz, SA; Feng, MG; Kline, RL; Lee, RM; Yang, LF | 1 |
Dedeoglu, IO; Springate, JE | 1 |
Asai, K; Kudej, AB; Kudej, RK; Natividad, F; Shen, YT; Takagi, G; Vatner, DE; Vatner, SF | 1 |
Ma, C; Xu, Y; Zhuang, Y | 1 |
Hocher, B; Mrowka, R; Patzak, A; Persson, PB; Storch, E | 1 |
Alvarez, A; Blazquez, MA; Piqueras, L; Sanz, MJ | 1 |
Coviello, A; de Bruno, MP; Jerez, S | 1 |
Biggi, A; Carra, N; Dall'aglio, P; Montanari, A; Novarini, A; Orrico, A; Perinotto, P; Valmadre, G | 1 |
Abe, Y; Fanzhu, L; Fujisawa, Y; Fukui, T; Guoxing, Z; Kimura, S; Kondo, N; Nishiyama, A; Ogawa, Y; Rahman, M | 1 |
Andersson, IJ; Bergström, G; Hedin, L; Jia, J; Wickman, A | 1 |
Almeida, AP; Ferreira, AJ; Santos, RA | 1 |
Bautista, R; Escalante, B; Hernández, J; Oyekan, A; Sánchez, A | 1 |
de Vries, R; Jan Danser, AH; Saxena, PR; Schuijt, MP | 1 |
Chandler, MP; Hintze, TH; Lopaschuk, GD; Osorio, JC; Panchal, AR; Recchia, FA; Stanley, WC; Xu, X | 1 |
Geng, MY; Guan, HS; Li, J; Zhu, HB | 1 |
Bascands, JL; Blaes, N; Escargueil-Blanc, I; Girolami, JP; Nazzal, D; Salvayre, R; Troly, M | 1 |
Frohlich, ED; Matsuoka, H; Ono, H; Ono, Y; Takanohashi, A | 1 |
Daigle, C; Dao, HH; deBlois, D; Demeilliers, B; Girardot, D; Martens, FM; Moreau, P | 1 |
Aubert, ML; Blum, WF; Dietz, R; Höhnel, K; Langenickel, T; Nüssler, AK; Pagel, I; Philipp, S; Willenbrock, R | 1 |
Duggan, KA; Hodge, G; Ye, VZ | 1 |
Borges, EL; Braga, AA; Cabral, BM; Neves, MJ; Rogana, E; Santos, RA | 1 |
Babar, S; Bauby, H; Parsons, RH; Rea, MS | 1 |
Frisbee, JC; Stepp, DW | 1 |
Adler, GK; Martinez, DV; Matsumura, M; Ochoa-Maya, M; Oestreicher, E; Rocha, R; Roubsanthisuk, W; Williams, GH | 1 |
Egashira, K; Katoh, M; Kubo-Inoue, M; Ohtani, K; Shimokawa, H; Takemoto, M; Takeshita, A; Usui, M | 1 |
Brands, MW; Fitzgerald, SM | 1 |
Andersen, JL; Bie, P; Sandgaard, NC | 1 |
Gui, Y; Hollenberg, M; Loutzenhiser, K; Loutzenhiser, R; Trottier, G; Wang, X | 1 |
Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lee, TY; Lin, HC; Liu, RS; Yang, YY | 1 |
Fukuda, N; Ikeda, Y; Jin, XQ; Kanmatsuse, K; Lai, YM; Miyazaki, H; Su, JZ; Suzuki, R; Tahira, Y; Takagi, H | 1 |
Bloch, KD; Bonventre, JV; Ichinose, F; Jones, RC; Sapirstein, A; Serhan, CN; Ullrich, R; Zapol, WM | 1 |
Durie, M; Levy, BI; Silvestre, JS; Tamarat, R | 1 |
Aukland, K; Roald, AB; Tenstad, O; Treeck, B | 1 |
Miettinen, A; Tikkanen, I; Uhlenius, N; Vuolteenaho, O | 1 |
Arican, N; Cimen, V; Elmas, I; Kalayci, R; Kaya, M; Korkut, F; Kucuk, M; Kudat, H | 1 |
Asakura, M; Asanuma, H; Funaya, H; Hori, M; Kim, J; Kitakaze, M; Node, K; Ogita, H; Sanada, S; Takashima, S | 1 |
Di Wang, H; Gopalakrishnan, V; Poduri, R; Shastri, S | 1 |
de Godoy, MA; de Oliveira, AM | 1 |
Wang, W; Wei, Y | 1 |
Coviello, A; Jerez, S; Peral de Bruno, M; Romano, L | 1 |
Ajayi, AA; Cory, J; Hayes, BE; Hercule, H; Oyekan, AO | 1 |
Adams, F; Boschmann, M; Christensen, NJ; Franke, G; Jordan, J; Klaus, S; Luft, FC; Sharma, AM; Stoffels, M; Tank, J | 1 |
Bouton, MC; Guillin, MC; Jandrot-Perrus, M; Michel, JB; Philippe, M; Richard, B; Rossignol, P | 1 |
Coviello, A; De Vito, E; Guardia, DC; Peral De Bruno, M; Romano, L; Vincent, PA | 1 |
Benzoni, D; Liu, KL; Lo, M; Sarkis, A | 1 |
Boomsma, F; van den Meiracker, AH; van der Linde, NA | 3 |
Accorsi-Mendonça, D; de Godoy, MA; de Oliveira, AM | 1 |
Hartshorne, DJ; Isaka, N; Ito, M; Kureishi, Y; Moriki, N; Nakano, T; Okamoto, R; Onishi, K; Seko, T | 1 |
Ferguson, AV; Latchford, KJ | 1 |
Badzyńska, B; Grzelec-Mojzesowicz, M; Sadowski, J | 1 |
Boffa, JJ; Chatziantoniou, C; Dussaule, JC; Fakhouri, F; Flamant, M; Tharaux, PL | 1 |
Chamorro, V; Moreno, JM; Osuna, A; Rodríguez-Gomez, I; Sainz, J; Vargas, F; Wangensteen, R | 1 |
Gerzanich, V; Ivanova, S; Simard, JM; Zhou, H | 1 |
Duarte, J; Moreno, JM; Osuna, A; Rodríguez-Gómez, I; Sainz, J; Vargas, F; Wangensteen, R | 1 |
Amiri, F; Iglarz, M; Neves, MF; Rozen, R; Schiffrin, EL; Touyz, RM; Virdis, A | 1 |
Knepper, MA; Turban, S; Wang, XY | 1 |
Bentley, MD; Fortepiani, LA; Garcia-Estan, J; Passardi, F; Ritman, EL; Romero, JC; Ruiz, MC | 1 |
Brands, MW; Cloud, LJ | 1 |
Babu, GJ; Dirksen, WP; Periasamy, M; Zhou, Y | 1 |
Kadekaro, M; Salas, N; Summy-Long, JY; Terrell, ML | 1 |
Cases, A; Gomez-Alamillo, C; Haas, JA; Juncos, LA; Romero, JC | 1 |
Bravo, J; Herrera-Acosta, J; Johnson, RJ; Quiroz, Y; Rodríguez-Iturbe, B | 1 |
Bravo, J; Herrera-Acosta, J; Johnson, RJ; Parra, G; Pons, H; Quiroz, Y; Rodríguez-Iturbe, B | 1 |
Akamine, EH; Carvalho, MH; Casarini, DE; Di Marco, GS; Fortes, ZB; Franco, Mdo C; Nigro, D; Tostes, RC | 1 |
Crozier, S; Endre, ZH; Gobe, G; Guan, Z; Manley, SW; Matthias, A; Willgoss, DA | 1 |
Ketabchi, F; Najafipour, H | 1 |
Adler, GK; Jonasson, L; Martinez-Vasquez, D; Mukasa, K; Oestreicher, EM; Roubsanthisuk, W; Stone, JR | 1 |
Bäcker, A; Heller, J; Horacek, V; Kramer, HJ; Vaneckova, I | 1 |
Ardaillou, R; Chansel, D; Dussaule, JC; Hus-Citharel, A; Stefanovic, V; Vandermeersch, S | 1 |
Brooks, VL; McKeogh, DF; O'Donaughy, TL | 1 |
Harada, M; Kitaura, Y; Komuro, I; Masaya, M; Minamino, T; Nagai, T; Sugaya, T; Terasaki, F; Toko, H; Zou, Y | 1 |
Anand-Srivastava, MB; Di Fusco, F | 1 |
Charo, IF; Egashira, K; Hiasa, K; Inoue, S; Ishibashi, M; Ishibashi, T; Kitamoto, S; Kura, S; Ohtani, K; Sugaya, T; Takeshita, A; Tsuchihashi, M; Tsuzuki, T; Zhao, Q | 1 |
Fukamizu, A; Harada, S; Hashimoto, T; Hashimoto, Y; Iguchi, T; Ishida, J; Kasuya, Y; Kihara, M; Matsuzaki, H; Mochizuki, N; Nishiwaki, S; Okunishi, H; Shiota, N; Sugaya, T; Sugiyama, F; Umemura, S; Yagami, K; Yamamoto, R | 1 |
Catanzaro, DF; Chen, R; Hu, L; Laragh, JH; Merali, C; Sealey, JE; Shi, Y; Zhou, Y | 1 |
Batenburg, WW; Bernasconi, CC; Danser, AH; Garrelds, IM; Juillerat-Jeanneret, L; Saxena, PR; van Kats, JP | 1 |
Hayashi, K; Homma, K; Kanda, T; Ozawa, Y; Saruta, T; Takamatsu, I; Tatematsu, S; Wakino, S; Yoshioka, K | 1 |
Kerwin, SY; Lu, J; Moochhala, SM; Ng, KC; Shirhan, M | 1 |
de Godoy, MA; de Oliveira, AM; Rattan, S | 1 |
Campbell, RC | 1 |
Kleinmann, F; Kupsch, E; Lai, EY; Mrowka, R; Patzak, A; Skelweit, A | 1 |
Bild, W; Boisteanu, D; Haulica, I; Ionita, T; Mihaila, C; Radasanu, O; Serban, DN; Serban, L | 1 |
Hollenberg, MD; Loutzenhiser, R; Wang, X | 1 |
Lee-Kwon, W; Pallone, TL; Pittner, J; Rhinehart, K; Solis, G; Welch, WJ; Wilcox, CS; Zhang, Z | 1 |
Fischer, LG; Freise, H; Hilpert, JH; Lauer, S; Sielenkämper, AW; Van Aken, H; Wendholt, D | 1 |
Corrêa, FM; Cunha, FQ; de Oliveira, AM; Fukada, SY; Iyomasa, MM | 1 |
Arun, KH; Kaul, CL; Poduri, R | 1 |
Arendshorst, WJ; Boffa, JJ | 1 |
Wang, YX | 1 |
Ahishali, B; Arican, N; Aydin, S; Bilgic, B; Elmas, I; Kalayci, R; Kaya, M; Kucuk, M; Uzun, H | 1 |
Ma, R; Wang, W; Zhu, GQ | 1 |
Grassi, G; Taddei, S | 1 |
Ahishali, B; Arican, N; Bilgic, B; Elmas, I; Kalayci, R; Kaya, M; Kucuk, M; Kudat, H; Uzun, H | 1 |
Eppel, GA; Evans, RG; Rajapakse, NW; Sampson, AK | 1 |
Mattson, DL; Meister, CJ | 1 |
MacLeod, KM; McNeill, JH; Nagareddy, PR; Xia, Z | 1 |
Cai, GJ; Shen, FM; Su, DF; Wang, DS; Xie, HH | 1 |
de Richelieu, LT; Holstein-Rathlou, NH; Salomonsson, M; Sorensen, CM | 1 |
de Carvalho, MH; Fernandes, L; Fortes, ZB; Loiola, RA; Nigro, D; Tostes, RC | 1 |
Duarte, FV; Faria-Silva, R; Santos, RA | 1 |
Gross, V; Habbel, S; Quack, I; Rump, LC; Sellin, L; Stegbauer, J; Vonend, O | 1 |
Ebinger, G; Hristova, I; Michotte, Y; Sarre, S; Stragier, B | 1 |
Alenina, N; Bader, M; Lemos, VS; Santos, RA; Silva, DM; Walther, T | 1 |
Coviello, A; Jerez, S; Peral de Bruno, M | 1 |
Alenina, N; Almeida, AP; Bader, M; Castro, CH; Ferreira, AJ; Santos, RA | 1 |
Bontscho, J; Godes, M; Hocher, B; Joehren, O; Kupsch, E; Lai, E; Patzak, A; Richter, CM; Skalweit, A; Steege, A; Thöne-Reineke, C; Zimmermann, M | 1 |
Liu, JL; Zucker, IH | 1 |
Abboud, HE; Feliers, D; Ghosh-Choudhury, G; Gorin, Y; Kasinath, BS | 1 |
Kim, HH; Liao, JK; Noma, K; Oyama, N; Rikitake, Y; Satoh, M; Wang, CY | 1 |
Clary, T; Fitch, RM; Powers, AF; Rubanyi, GM; Rutledge, JC; Tseng, JL; Wang, YX | 1 |
Campbell, DJ | 1 |
de Godoy, MA; de Oliveira, AM; Fukada, SY; Tirapelli, CR | 1 |
Dixon, LJ; El-Sherbeeny, N; Hamilton, PB; Hanratty, CG; Johnston, GD; Leahey, WJ; McGrath, LT; McVeigh, GE; Morgan, DR | 1 |
Ciobanu, A; Costuleanu, M; Gurzu, B; Petrescu, G; Slatineanu, SM | 1 |
Chong, T; Ramirez, R; Victorino, GP | 1 |
Endre, ZH; Gobé, G; Guan, Z; Willgoss, D | 1 |
Drenjancevic-Peric, I; Friesema, J; Lombard, JH; McEwen, S; Roman, RJ; Schulta, D; Yu, M; Zhu, J | 1 |
de Arruda Camargo, LA; dos Santos, TA; Guarda, IF; Saad, WA | 1 |
Accorsi-Mendonça, D; Corrêa, FM; Oliveira, AM | 1 |
Chakravarty, S; Dugar, S; Kerr, I; Li, Z; Ma, JY; Protter, AA; Schreiner, G | 1 |
Chen, YJ; Li, J; Quilley, J | 1 |
An, WS; Gao, YJ; Lee, RM; Lu, C; Sharma, AM; Su, LY; Takemori, K | 1 |
Adler, GK; Burr, D; Guo, C; Jonasson, L; Kikuchi, T; Martinez-Vasquez, D; Mayoral, S; Oestreicher, EM; Ricchiuti, V; Roubsanthisuk, W; Seely, EW; Yao, T | 1 |
Almeida, AP; Araújo, CA; Caliari, MV; Ferreira, AJ; Jacoby, BA; Macedo, FA; Santos, RA; Silva, GA | 1 |
Breaks, J; Loutzenhiser, K; Loutzenhiser, R; Wang, X | 1 |
Achike, FI; Chin, LC; Mustafa, MR | 1 |
Campagnole-Santos, MJ; Cortes, SF; Lemos, VS; Santos, RA; Silva, DM; Vianna, HR | 1 |
Hussain, T; Siddiqui, AH | 1 |
Barton, M; Bhattacharya, I; Haas, E; Hofmann-Lehmann, R; Kretz, M; Minotti, R; Mundy, AL; Widmer, CC | 1 |
Clempus, RE; Dikalov, SI; Griendling, KK; Guzik, TJ; Harrison, DG; Jones, DP; Mueller, CF; Schmidt, HH; Widder, JD | 1 |
Black, S; Cassis, LA; Gibson, LL; Hahner, L; Osborne-Lawrence, S; Samols, D; Schwartz, R; Shaul, PW; Thomas, GD; Vongpatanasin, W | 1 |
Huang, Y; Lau, CW; Lin, SG; Yu, XY; Yung, LM; Zhong, JC | 1 |
Ishiguro, K; Itoh, H; Sakamaki, Y; Saruta, T; Sasamura, H | 1 |
Chen, J; Fan, F; Han, L; Wang, S; Wang, X; Xie, X; Yan, J; Zhou, X | 1 |
Huang, T; Lombard, JH; Zhu, J | 1 |
Antunes-Rodrigues, J; Elias, LL; Giusti-Paiva, A; Gomes, DA; Margatho, LO; Reis, WL; Ventura, RR | 1 |
Chlopicki, S; Fedorowicz, A; Kozlovski, VI; Lomnicka, M | 1 |
Gironacci, MM; Peña, C; Polizio, AH; Tomaro, ML | 1 |
Chataigneau, M; Diallo, AS; Etienne-Selloum, N; Geffard, M; Muller, B; Sarr, M; Schini-Kerth, VB; Schott, C; Stoclet, JC | 1 |
Dechend, R; Dietz, R; Gross, V; Henke, N; Luft, FC; Muller, DN; Obst, M; Park, JK; Qadri, F; Scheidereit, C; Schmidt-Ullrich, R; Wellner, M | 1 |
Chen, FP; He, SL; Li, YJ; Ma, QL; Peng, ZY; Sun, M; Tang, CE; Yang, TL | 1 |
Fujisawa, Y; Izuishi, K; Kimura, S; Miyanaka, H; Nagai, Y; Nakagawa, T; Nishiyama, A; Ohmori, K; Zhang, GX | 1 |
Alenina, N; Bader, M; da Costa Gonçalves, AC; Fraga-Silva, RA; Leite, R; Pinheiro, SV; Reis, AB; Reis, FM; Santos, RA; Touyz, RM; Webb, RC | 1 |
Benter, IF; Kehinde, EO; Yousif, MH | 1 |
Coviello, A; de Bruno, MP; Herrera, RN; Marañón, RO; Muntaner, J; Proto, V; Turoni, CM | 1 |
Campagnole-Santos, MJ; Carvalho, MB; da Mata Machado, LT; de Paula, RD; Duarte, FV; Faria-Silva, R; Fauler, B; Santos, RA | 1 |
Avila-Casado, MC; Escalante, B; Medina, A; Rios, A; Robles, HV; Romo, E; Sanchez-Mendoza, A; Soto, V | 1 |
Brinkmann, JO; Gericke, A; Kupsch, E; Lai, EY; Patzak, A; Persson, PB; Seeliger, E; Skalweit, A; Spielmann, N; Steege, A; Stegbauer, J | 1 |
Kuczka, Y; Langnaese, K; Patzak, A; Quack, I; Rump, LC; Sellin, L; Steege, A; Stegbauer, J; Vonend, O | 1 |
Connors, SG; Mendonca, M; Palm, F; Welch, WJ; Wilcox, CS | 1 |
Chen, JZ; Jin, DD; Liu, YY; Wang, SJ; Wang, XX; Yang, YM | 1 |
Brosnihan, KB; Ferrario, CM; Figueroa, JP; Ganten, D; Li, P | 1 |
Carlström, M; Eriksson, UJ; Lai, EY; Ma, Z; Patzak, A; Persson, AE; Sendeski, M; Steege, A; Zabihi, S | 1 |
Igarashi, J; Kosaka, H; Kubota, Y; Moriue, T; Nakai, K; Yoneda, K | 1 |
Hou, Y; Matsuo, O; Okada, K; Okamoto, C; Ueshima, S | 1 |
Batenburg, WW; Jan Danser, AH; Oosterveer, CR; van Esch, JH; van Veghel, R | 1 |
Akira, T; Egi, Y; Maruyama, T; Matsumura, Y; Ohkita, M; Sasaoka, T; Takaoka, M; Tawa, M; Yamamoto, A | 1 |
Badejo, AM; Casey, DB; Dhaliwal, JS; Gallen, TB; Greco, AJ; Kadowitz, PJ | 1 |
Buxton, BF; Hare, DL; Wookey, PJ; Ye, B; Zulli, A | 1 |
Adler, GK; Lian, CG; Oestreicher, EM; Ricchiuti, V; Seely, EW; Stone, JR; Tran, L; Williams, GH; Yao, T | 1 |
Costa, CA; Criddle, DN; Espinoza, LA; Marins de Carvalho, LC; Ognibene, DT; Oliveira, PR; Resende, AC; Soares de Moura, R; Tano, T | 1 |
Brown, RD; Carlström, M; Lai, EY; Ma, Z; Patzak, A; Persson, AE | 1 |
Bravo, Y; Chavez, M; Johnson, RJ; Parra, G; Pons, H; Quiroz, Y; Rodriguez-Iturbe, B; Salazar, J | 1 |
Garvin, JL; Ramseyer, VD | 1 |
Coviello, A; de Bruno, MP; Joo Turoni, CM; Marañón, RO | 1 |
Agharazii, M; Bélanger, S; Larivière, R; Lebel, M; Lemieux, P; Therrien, F | 1 |
Bader, M; Felipe, SA; Martin, RP; Oliveira, SM; Rodrigues, ES; Shimuta, SI | 1 |
Guo, F; Hay, M; Johnson, AK; Singh, M; Xue, B | 1 |
O'Rourke, ST; Qian, SY; Sun, C; Yao, F; Zhang, Q | 1 |
Cho, HS; Kim, WK; Lee, J; Park, S | 1 |
Carneiro, FS; Giachini, FR; Inscho, EW; Lima, VV; Osmond, DA; Tostes, RC; Webb, RC; Zhang, S | 1 |
Drummond, GR; Harrison, CB; Selemidis, S; Sobey, CG | 1 |
McLemore, GR; Ryan, MJ; Stec, DE; Storm, MV; Vera, T | 1 |
Ahishali, B; Arican, N; Bilgic, B; Elmas, I; Kalayci, R; Kaya, M; Küçük, M; Uzun, H | 1 |
Baron-Menguy, C; Cousin, M; Custaud, MA; Dumont, O; Guihot, AL; Henrion, D; Loufrani, L; Subra, JF; Toutain, B; Vessières, E | 1 |
Cassis, LA; Daugherty, A; Guo, Z; McNamara, CA; Moorleghen, JJ; Owens, AP; Subramanian, V | 1 |
Adler, GK; Coutinho, P; Guo, C; Lapointe, N; Loutraris, P; Pojoga, LH; Ricchiuti, V; Romero, JR; Stone, JR; Williams, GH; Yao, TM | 1 |
Alonso, F; Haefliger, JA; Krattinger, N; Mazzolai, L; Meda, P; Simon, A; Waeber, G | 1 |
Beauregard, KG; Khalil, RA; Qiao, X; Raffetto, JD | 1 |
Castillo, C; Castillo, EF; López, RM; Pérez, T | 1 |
Castillo, C; Castillo, EF; Castillo, MC; López, RM; Pérez, T | 1 |
Dikalov, S; Dikalova, AE; Góngora, MC; Griendling, KK; Harrison, DG; Lambeth, JD | 1 |
Chappell, MC; Diz, DI; Gwathmey, TM; Pirro, NT; Rose, JC; Tang, L; Westwood, BM | 1 |
Czabanka, M; Eklund, L; Heljasvaara, R; Ilves, M; Janmey, P; Kerkelä, R; Leskinen, H; Peuhkurinen, K; Pihlajaniemi, T; Piuhola, J; Rasi, K; Ruskoaho, H; Rysä, J; Sormunen, R; Vajkoczy, P; Vuolteenaho, O | 1 |
Durand, MJ; Greene, AS; Lombard, JH; Moreno, C | 1 |
Barreto-Chaves, ML; Carrillo-Sepúlveda, MA; Chies, AB; da Silva, OG; Rossignoli, Pde S | 1 |
Antunes-Rodrigues, J; Camargo, LA; Elias, LL; Reis, WL; Saad, WA | 1 |
Castania, JA; Durand, Mde T; Fazan, R; Salgado, HC; Salgado, MC | 1 |
de Bruno, MP; Herrera, R; Marañón, RO; Proto, V; Turoni, CJ | 1 |
Cowley, AW; Lu, L; Polichnowski, AJ | 1 |
Aguilar, MI; Bosnyak, S; Clayton, D; Del Borgo, MP; Hausler, N; Jones, ES; Kirsch, JF; Perlmutter, P; Thomas, WG; Unabia, S; Welungoda, I; Widdop, RE | 1 |
Al-Saleh, FM; Benter, IF; Chappell, MC; Diz, DI; Raghupathy, R; Yousif, MH | 1 |
Bautista, R; Franco, M; Kobori, H; Navar, LG; Osorio, H; Pacheco, U; Sánchez-Lozada, LG; Santamaría, J; Soto, V; Tapia, E | 1 |
Chan, P; Chen, PY; Cheng, TH; Hong, HJ; Lin, JG; Lin, LJ; Liu, JC | 1 |
Baylis, C; Molnar, M; Sasser, JM | 1 |
Bie, P; Høilund-Carlsen, PF; Rasmussen, MS; Simonsen, JA; Vach, W | 1 |
Dautzenberg, M; Just, A; Keilhoff, G | 1 |
de Bruno, MP; Jerez, S; Sierra, L | 1 |
Kang, KT; Loria, AS; Pollock, DM; Pollock, JS | 1 |
Banday, AA; Javkhedkar, AA; Lokhandwala, MF | 1 |
Chia, E; Kagota, S; McGuire, JJ; Wijekoon, EP | 1 |
Carlström, M; Fredholm, BB; Gao, X; Patzak, A; Persson, AE; Sällström, J; Scheffer, PG; Sendeski, M; Teerlink, T | 1 |
Smith, FG; Wehlage, SJ | 1 |
Adler, GK; Coutinho, P; Maldonado, ER; Pojoga, LH; Rivera, A; Romero, JR; Turchin, A; Williams, GH; Williams, J; Yao, TM; Youte, R | 1 |
Castro-Moreno, P; Figueroa-Guillén, ES; Gallardo-Ortíz, IA; Godínez-Hernández, D; Ibarra-Barajas, M; Rivera-Jardón, FF | 2 |
Ebenezar, KK; Smith, FG; Wong, AK | 1 |
Du, C; Hu, X; Tu, S; Wang, K; Xie, X; Zhang, F | 1 |
Gao, X; Su, L; Wang, X; Xing, H; Yang, Y | 1 |
Chang, CJ; Dickinson, BC; Guo, Q; Hu, C; Ito, S; Lu, Y; Miyata, T; Mori, T; Nakamichi, T; Oba, I; Ogawa, S; Ohsaki, Y; Sato, E; Sato, H; Sun, Y; Yoneki, Y | 1 |
Crawford, C; Desai, T; Kennedy-Lydon, T; Munday, J; Peppiatt-Wildman, CM; Sawbridge, L; Sprott, C; Unwin, RJ; Wildman, SS | 1 |
Behnke, BJ; Delp, MD; Dominguez, JM; Donato, AJ; Lesniewski, LA; Muller-Delp, J; Park, Y; Prisby, RD | 1 |
Lai, EY; Liu, ZZ; Patzak, A; Perlewitz, A; Persson, PB; Sendeski, MM; Viegas, VU | 1 |
da Costa Gonçalves, AC; Fraga-Silva, RA; Leite, R; Santos, RA | 1 |
Amin, A; Badr El-Din, NK; Choi, SK; Kadowitz, P; Kevil, CG; Matrougui, K; Navar, LG; Osman-Elazeik, Y; Trebak, M | 1 |
Boim, MA; Carvalho, LN; Cristovam, PC; Passos, CS | 1 |
Bader, M; Martin, RP; Merino, VF; Nakaie, CR; Oliveira, SM; Pesquero, JB; Rodrigues, ES; Sabatini, RA; Shimuta, SI; Silva, RF | 1 |
Bürgelová, M; Červenka, L; Hammock, BD; Honetschlägerová, Z; Husková, Z; Hwang, SH; Imig, JD; Kitada, K; Kopkan, L; Kramer, HJ; Kujal, P; Nishiyama, A; Sporková, A; Varcabová, Š; Vernerová, Z | 1 |
Hoe, SZ; Lam, SK; Ng, HK; Poh, TF | 1 |
Adams, GN; Bilodeau, ML; Chen, A; Fang, C; Grobe, N; LaRusch, G; Mahdi, F; Morris, M; Nieman, MT; Schmaier, AA; Schmaier, AH; Stavrou, E; Warnock, M; Zhou, Y | 1 |
Helle, F; Hultström, M; Iversen, BM; Palm, F; Schwartz, D; Schwartz, IF; Skogstrand, T | 1 |
Dikalov, SI; Harrison, DG; Hummler, E; Pech, V; Rossier, BC; Thumova, M; Wall, SM | 1 |
Baptista, Rde F; Chies, AB; de Lábio, RW; Payão, SL; Rossignoli, Pde S | 1 |
Bachmann, S; Bernstein, KE; Delpire, E; Eladari, D; Fletcher, NK; Fuchs, S; Giani, JF; Gonzalez-Villalobos, RA; Janjoulia, T; McDonough, AA; Navar, LG; Nguyen, MT; Peti-Peterdi, J; Picard, N; Riquier-Brison, AD; Seth, DM | 1 |
Biggi, A; Boeti, L; Cabassi, A; Cherney, DZ; Crocamo, A; Montanari, A; Musiari, L; Pelà, G | 1 |
Fukui, K; Irie, D; Kato, T; Kawahito, H; Kishida, S; Matsubara, H; Miyagawa, S; Takata, H; Wakana, N; Yamada, H | 1 |
Abdulla, MH; Johns, EJ | 2 |
Bailey, MA; Dear, JW; Hollis, LM; Jansen, MA; Lennen, RJ; Menzies, RI; Mullins, JJ; Sanguinetti, G; Webb, DJ; Zammit-Mangion, A | 1 |
Bernstein, KE; Blackwell, WL; Delpire, E; Fuchs, S; Giani, JF; Gonzalez-Villalobos, RA; Janjulia, T; Kamat, N; McDonough, AA; Seth, DM; Shah, KH; Shen, XZ; Toblli, JE | 1 |
Akamine, EH; Aragão, DS; Carvalho, MH; Casarini, DE; Filgueira, FP; Fortes, ZB; Hagihara, GN; Lobato, NS | 1 |
Flavahan, NA; Flavahan, S; Leung, SW; Vanhoutte, PM; Xu, A; Zhao, Y | 1 |
Duquette, N; Luo, X; Thorin, E; Thorin-Trescases, N; Yu, C | 1 |
Berger, JM; Brégeon, J; Calderon, C; Cariou, B; Hadchouel, J; Le May, C; Loirand, G; Prieur, X; Vaillant, N | 1 |
Del Valle-Mondragón, L; Guzmán-Hernández, EA; Ibarra-Barajas, M; Pastelín-Hernández, G; Sánchez-Mendoza, MA; Villalobos-Molina, R | 1 |
Ikeda, H; Kitazono, T; Noguchi, H; Suehiro, T; Tokumoto, M; Toyonaga, J; Tsuruya, K; Yamada, S | 1 |
Llinás, MT; López, R; Salazar, E; Salazar, FJ | 1 |
Chatsudthipong, V; Kongrat, S; Muanprasat, C; Srisawat, U | 1 |
Bernstein, KE; Li, L; Li, Y; Lyden, P; Shah, KH; Shen, XZ; Shi, P | 1 |
Bernstein, KE; Giani, JF; Gonzalez-Villalobos, RA; Han, J; Janjulia, T; McDonough, AA; Rodriguez-Iturbe, B; Shen, XZ; Toblli, JE | 1 |
Adler, GK; Khalil, RA; Opsasnick, LA; Pojoga, LH; Reslan, OM; Siddiqui, WT; Williams, GH; Yao, TM | 1 |
Bernstein, EA; Bernstein, KE; Giani, JF; Harrison, DG; Janjulia, T; Li, Y; Shah, KH; Shen, XZ; Shi, P; Zhao, T | 1 |
Araújo, LD; De Maria, ML; Ferreira, AJ; Fraga-Silva, RA; Menezes, GB; Pereira, LA; Raizada, MK; Ribeiro, HJ; Shenoy, V | 1 |
Heeba, GH; Morsy, MA | 1 |
Cribbs, DH; Gillen, DL; Kilday, K; Passos, GF; Vasilevko, V | 1 |
Cao, TN; Cordero-Reyes, AM; Gupte, AA; Hamilton, DJ; Li, S; Smith, JA; Torre-Amione, G; Vedula, I; Youker, KA; Zhang, A | 1 |
Bhimaraj, A; Celis, R; Cordero-Reyes, AM; Estep, JD; Flores-Arredondo, JH; Hamilton, DJ; Orrego, CM; Torre-Amione, G; Trevino, AR; Youker, KA | 1 |
Brzozowski, T; Konturek, SJ; Korbut, R; Kwiecien, S; Madej, J; Olszanecki, R; Pajdo, R; Pawlik, MW; Ptak-Belowska, A; Suski, M; Targosz, A | 1 |
Ganji, SK; Gopoju, R; Kanugula, AK; Karnewar, S; Kotamraju, S; Kumar, JM; Prabhakar, S; Rangaraj, N; Tupperwar, N; Vasamsetti, SB | 1 |
Lionetti, V | 1 |
Burke, SD; Clark, CD; DuPont, JJ; Jaffe, IZ; Kang, PM; Karumanchi, SA; Khankin, EV; Lo, AS; McCurley, A; Moss, ME; Rajakumar, A; Seely, EW; Stillman, IE; Wang, A; Zhang, D; Zsengellér, ZK | 1 |
Bernstein, EA; Bernstein, KE; Eriguchi, M; Fuchs, S; Giani, JF; Gonzalez-Villalobos, RA; Katsumata, M; Li, L; McDonough, AA; Shen, XZ | 1 |
Hu, M; Jia, Y; Li, J; Li, L; Rong, R; Zhang, C; Zheng, L; Zhu, T | 1 |
Baptista, RFF; Chies, AB; de Lábio, RW; de Oliveira, PB; Payão, SLM; Rossignoli, PS | 1 |
Högner, A; Lai, EY; Liu, ZZ; Mathia, S; Pahlitzsch, T; Patzak, A; Persson, PB; Rosenberger, C; Schubert, R; Wennysia, IC; Xu, MZ | 1 |
Chang, NB; He, YZ; Jiang, J; Jiang, R; Li, T; Sun, XL; Xu, JY | 1 |
Ashpole, N; Csiszar, A; Fulop, GA; Gautam, T; Giles, CB; Sonntag, WE; Springo, Z; Tarantini, S; Ungvari, Z; Valcarcel-Ares, NM; Wren, JD; Yabluchanskiy, A | 1 |
Akamine, EH; Aparecida de Oliveira, M; Araujo, PX; Ceravolo, GS; Colli, LG; Costa, TJ; Dantas, AP; de Carvalho, MHC; Echem, C; Jiménez-Altayó, F; Santos-Eichler, RA; Vila, E | 1 |
Islam, MZ; Miyamoto, A; Shiraishi, M; Van Dao, C | 1 |
Amaral, TAS; Carvalho, LCRM; Costa, CA; Moura, RS; Ognibene, DT; Resende, AC; Rocha, APM | 1 |
Fraidenburg, DR; Han, Y; Ren, X; Sun, S; Tang, H; Zhang, F; Zhao, M; Zhao, Z | 1 |
Smith, FG; Vinturache, AE | 1 |
Chang, W; Li, J; Xu, N; Yuan, W; Zhang, W | 1 |
Endres, BT; Geurts, AM; Ilatovskaya, DV; Levchenko, V; Palygin, O; Staruschenko, A | 1 |
Campbell, WB; Falck, JR; Gauthier, KM; Kriska, T; Shah, AJ | 1 |
Aziz, NM; El-Tahawy, NF; Elbassuoni, EA | 1 |
Arranz, C; Caniffi, C; Elesgaray, R; Gobetto, MN; Juriol, LV; Mendes Garrido Abregú, F; Tomat, AL | 1 |
Achard, JM; Bejaoui, M; Ben Abdennebi, H; Javellaud, J; Tabka, D | 1 |
Morsy, MD | 1 |
Haefliger, JA; Kurtz, A; Le Gal, L; Mazzolai, L; Meda, P; Pellegrin, M; Santoro, T; Wagner, C | 1 |
Cai, GW; Cheng, P; Ding, L; Gao, S; Hu, J; Huang, GY; Wang, L; Zhang, YX | 1 |
Abo El Enein, A; Al Dreny, BA; Ramadan, NM; Rashed, LA; Sabry, MM | 1 |
Chies, AB; Oliveira, PB; Oliveira, PR; Rossignoli, PS; Spadella, MA | 1 |
Bellini, C; Caulk, AW; Ferruzzi, J; Humphrey, JD; Murtada, SI; Spronck, B | 1 |
Aluko, EO; Fasanmade, AA; Nna, VU | 1 |
Al-Motrefi, AA; Alorainey, BI; Bukhari, IA; Campbell, WB; Hammock, BD; Mahmoud, A | 1 |
Kamkar-Del, Y; Mohebbati, R; Shafei, MN | 1 |
Benardeau, A; Braun, D; Golz, S; Lai, EY; Lichtenberger, FB; Patzak, A; Persson, PB; Schomber, T; Schubert, R; Summer, H; Wennysia, IC; Xu, MZ; Zhao, L | 1 |
Chen, JW; Jiang, Y; Liu, D; Murao, K; Sun, WP; Wang, LH; Xue, R; Zhang, GX | 1 |
Adler, J; Aïssi, D; Duque Escobar, J; Längst, N; Lukowski, R; Müller, C; Schweigert, O; Tong, T; Trégouët, DA; Zeller, T | 1 |
Berkban, T; Kanla, P; Mothong, W; Pakdeechote, P; Prachaney, P; Saengnak, B; Samrid, R | 1 |
Huang, S; Jia, Z; Niu, Y; Shi, W; Wang, S; Yu, J; Zhang, A; Zhang, Y; Zhou, W | 1 |
Dang, Q; Han, C; Li, M; Li, P; Li, Y; Li, Z; Yang, Y | 1 |
6 review(s) available for angiotensin ii and ng-nitroarginine methyl ester
Article | Year |
---|---|
The potential role of nitric oxide in angiotensin II-receptor blockade.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Humans; Hypertension; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred SHR; Receptors, Angiotensin | 1996 |
Role of nitric oxide in the control of glomerular microcirculation.
Topics: Angiotensin II; Animals; Kidney; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Vasoconstrictor Agents | 1997 |
Endothelin: role in experimental hypertension.
Topics: Angiotensin II; Animals; Desoxycorticosterone; Disease Models, Animal; Endothelin-1; Fructose; Hypertension; Insulin Resistance; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred Dahl; Rats, Inbred SHR | 2000 |
[Vasoactive peptides and the development of renal sclerosis: contribution of transgenes].
Topics: Angiotensin II; Animals; Collagen Type II; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Fibrosis; Genes, Reporter; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Luciferases; MAP Kinase Signaling System; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renin-Angiotensin System; Sclerosis; Transforming Growth Factor beta; Transgenes | 2002 |
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice.
Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cardiac Output, High; Cardiomegaly; Cardiovascular System; Enzyme Inhibitors; Estradiol; Hypercholesterolemia; Hyperglycemia; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Phenotype; Simvastatin | 2005 |
Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.
Topics: Angiotensin II; Animals; Baroreflex; Cardiac Output, Low; Disease Models, Animal; Excitatory Postsynaptic Potentials; Exercise; Heart Failure; Hemodynamics; Humans; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rabbits; Risk Factors; Sensitivity and Specificity; Sympathetic Nervous System | 2000 |
7 trial(s) available for angiotensin ii and ng-nitroarginine methyl ester
Article | Year |
---|---|
Influence of nitric oxide on hypoglycemia--or angiotensin II-stimulated ACTH and GH secretion in normal men.
Topics: Adrenocorticotropic Hormone; Adult; Angiotensin II; Blood Glucose; Enzyme Inhibitors; Human Growth Hormone; Humans; Hypoglycemia; Hypoglycemic Agents; Infusions, Intravenous; Injections, Intravenous; Insulin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase | 1996 |
Angiotensin II blockade does not prevent renal effects of L-NAME in sodium-repleted humans.
Topics: Adult; Angiotensin II; Biphenyl Compounds; Enzyme Inhibitors; Female; Humans; Imidazoles; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Sodium, Dietary; Tetrazoles | 1997 |
Angiotensin II and prostaglandin interactions on systemic and renal effects of L-NAME in humans.
Topics: Adult; Angiotensin II; Blood Pressure; Cyclooxygenase Inhibitors; Drug Synergism; Enzyme Inhibitors; Female; Humans; Indomethacin; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Prostaglandins; Renal Circulation; Sodium; Vasoconstriction | 2001 |
Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects.
Topics: Angiotensin II; Antihypertensive Agents; Diuresis; Diuretics; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Glomerular Filtration Rate; Hemodynamics; Hormones; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Natriuresis; NG-Nitroarginine Methyl Ester; Renal Circulation; Sodium Chloride Symporter Inhibitors | 2003 |
Potentiation of L-NAME-induced systemic and renal vasoconstrictor responses by alpha1-adrenoceptor antagonism.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Angiotensin II; Blood Pressure; Drug Synergism; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Renal Circulation; Sympathetic Nervous System; Vascular Resistance; Vasoconstriction | 2005 |
Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure.
Topics: Acetylcholine; Aged; Angiotensin II; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Endothelium-Dependent Relaxing Factors; Fatty Acids, Omega-3; Female; Forearm; Heart Failure; Humans; Male; NG-Nitroarginine Methyl Ester; Nitroprusside; Olive Oil; Plant Oils; Plethysmography | 2006 |
Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 1; Enzyme Inhibitors; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Losartan; Male; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renal Circulation; Renin-Angiotensin System; Signal Transduction; Up-Regulation; Young Adult | 2013 |
452 other study(ies) available for angiotensin ii and ng-nitroarginine methyl ester
Article | Year |
---|---|
Angiotensin dependence of endothelium-mediated renal hemodynamics.
Topics: Angiotensin II; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Enalaprilat; Endothelium, Vascular; Hemodynamics; Imidazoles; Kinins; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrazoles | 1992 |
A comparison of the characteristics of angiotensin receptors in the renal and mesenteric vascular beds of the anesthetized cat.
Topics: Angiotensin II; Angiotensin III; Animals; Arginine; Cats; Female; Indomethacin; Injections, Intra-Arterial; Injections, Intravenous; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Receptors, Angiotensin; Renal Artery; Saralasin; Vasoconstriction | 1992 |
Evidence that nitric oxide modulates drinking behaviour.
Topics: Angiotensin II; Animals; Arginine; Drinking Behavior; Drug Synergism; Injections; Injections, Intraventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Preoptic Area; Rats; Rats, Inbred Strains; Stereoisomerism; Water Deprivation | 1992 |
Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
Topics: Angiotensin II; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Calcitonin Gene-Related Peptide; Captopril; Endothelins; Heart Rate; Hemodynamics; Hindlimb; Imidazoles; In Vitro Techniques; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitroarginine; Rats; Regional Blood Flow; Renal Circulation; Splanchnic Circulation; Tetrazoles; Vasoconstriction | 1991 |
High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles.
Topics: Acetylcholine; Angiotensin II; Animals; Arginine; Arterioles; Diabetes Mellitus; Glucose; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Perfusion; Rabbits; Vasodilation | 1995 |
Role of nitric oxide in modulating the vasoconstrictor actions of angiotensin II in preglomerular and postglomerular vessels in dogs.
Topics: Angiotensin II; Animals; Arginine; Dogs; Hydrostatic Pressure; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renal Circulation; Vascular Resistance; Vasoconstriction | 1995 |
Selective inhibition of pressor and haemodynamic effects of NG-nitro-L-arginine by halothane.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Arginine; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Drug Interactions; Halothane; Heart Rate; Hemodynamics; Injections, Intravenous; Microspheres; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroarginine; Norepinephrine; Rats; Rats, Sprague-Dawley; Vascular Resistance | 1993 |
Effects of phospholipids on renal function.
Topics: Angiotensin II; Animals; Arginine; Diuresis; Dogs; Hemodynamics; Kidney; Lysophosphatidylcholines; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Platelet Activating Factor; Rats; Renal Artery; Renal Circulation; Structure-Activity Relationship; Vasodilation; Vasopressins | 1993 |
[Sodium intake and angiotensin in hypertension induced by chronic NO synthase inhibition in the rat].
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Arginine; Diet, Sodium-Restricted; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Sodium, Dietary | 1993 |
Angiotensin II neurotransmitter actions in paraventricular nucleus are potentiated by a nitric oxide synthase inhibitor.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Arginine; Blood Pressure; Electric Stimulation; Heart Rate; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Subfornical Organ | 1994 |
Endogenous vasoactive systems and the pressor effect of acute N omega-nitro-L-arginine methyl ester administration.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Desoxycorticosterone; Diet, Sodium-Restricted; Enalapril; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nicardipine; Nitric Oxide; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Vasoconstriction | 1994 |
Angiotensin IV reverses the acute cerebral blood flow reduction after experimental subarachnoid hemorrhage in the rat.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Arginine; Blood Pressure; Cerebral Arteries; Cerebrovascular Circulation; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Time Factors | 1994 |
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Topics: Adrenergic beta-Antagonists; Amino Acid Oxidoreductases; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Heart; Imidazoles; Losartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Ramipril; Receptors, Angiotensin; Receptors, Bradykinin; Tetrazoles | 1995 |
Blood pressure (BP) and renal vasoconstrictor responses to acute blockade of nitric oxide: persistence of renal vasoconstriction despite normalization of BP with either verapamil or sodium nitroprusside.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arginine; Blood Pressure; Calcium Channel Blockers; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasoconstrictor Agents; Verapamil | 1995 |
Interactions between angiotensin and nitric oxide in the renal response to volume expansion.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Blood Volume; Captopril; Dogs; Female; Hemodynamics; Kidney; Lithium; Male; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renal Circulation; Renin-Angiotensin System | 1995 |
Angiotensin-II-induced increase in transcoronary protein clearance: role of hypertension vs. nitric oxide or cyclo-oxygenase products.
Topics: Angiotensin II; Animals; Arginine; Arteries; Blood Pressure; Coronary Vessels; Cyclic GMP; Cyclooxygenase Inhibitors; Dinoprostone; Dogs; Indomethacin; Lymph; Male; Metabolic Clearance Rate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Proteins; Vasoconstrictor Agents | 1995 |
Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase.
Topics: Angiotensin II; Animals; Arginine; Drug Synergism; Endomyocardial Fibrosis; Enzyme Inhibitors; Extracellular Matrix Proteins; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; RNA, Messenger | 1995 |
Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Arginine; Coronary Vessels; Data Interpretation, Statistical; Dogs; In Vitro Techniques; Kinins; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Peptide Fragments; Receptors, Angiotensin; Stimulation, Chemical | 1995 |
Analysis of responses to angiotensin peptides in the hindquarters vascular bed of the cat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Angiotensins; Animals; Arachidonic Acid; Arginine; Blood Flow Velocity; Captopril; Cats; Dose-Response Relationship, Drug; Female; Hindlimb; Imidazoles; Male; Meclofenamic Acid; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Acid; Phentolamine; Prostaglandin Endoperoxides, Synthetic; Pyridines; Regional Blood Flow; Tetrazoles; Thromboxane A2; Vasoconstrictor Agents | 1995 |
Enhanced responses to L-arginine in aortic rings from rats with angiotensin-dependent hypertension.
Topics: Angiotensin II; Animals; Aorta; Aortic Coarctation; Arginine; Blood Pressure; Hypertension; In Vitro Techniques; Male; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Rats; Rats, Sprague-Dawley | 1995 |
Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II.
Topics: Analysis of Variance; Angiotensin II; Animals; Arginine; Biphenyl Compounds; Enzyme Precursors; Enzyme Repression; Gene Expression Regulation, Enzymologic; Imidazoles; Indomethacin; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Ramipril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrazoles | 1995 |
Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds.
Topics: Amino Acid Oxidoreductases; Angiotensin I; Angiotensin II; Angiotensin III; Animals; Arginine; Biphenyl Compounds; Cats; Hindlimb; Imidazoles; Losartan; Meclofenamic Acid; Mesenteric Artery, Superior; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Perfusion; Tetrazoles; Vascular Resistance; Vasoconstriction | 1993 |
Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Bradykinin; Carotid Arteries; Imidazoles; Kinins; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin; Receptors, Neurotransmitter; Tetrazoles; Tunica Intima | 1993 |
Nitric oxide regulates migrating motor complex cycling and its postprandial disruption.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Arginine; Dogs; Eating; Fasting; Female; Male; Myoelectric Complex, Migrating; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Stomach | 1993 |
Heparin attenuates the effect of mitogenic vasoconstrictors on mesangial cell proliferation and handling of immunoglobulin G complexes.
Topics: Angiotensin II; Animals; Arginine; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Endothelins; Glomerular Mesangium; Heparin; Immunoglobulin G; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 1995 |
Regional haemodynamic effects of human and rat adrenomedullin in conscious rats.
Topics: Adrenomedullin; Angiotensin II; Animals; Antihypertensive Agents; Arginine; Blood Pressure; Calcitonin Gene-Related Peptide; Catheterization, Peripheral; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Humans; Hypertension; Hypotension; Laser-Doppler Flowmetry; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Peptides; Random Allocation; Rats; Regional Blood Flow; Renal Circulation; Tachycardia; Vasopressins | 1995 |
L-arginine analogues inhibit aldosterone secretion in rats.
Topics: Aldosterone; Angiotensin II; Animals; Arginine; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroarginine; Rats; Rats, Sprague-Dawley | 1995 |
The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat.
Topics: Angiotensin II; Animals; Arginine; Blood Pressure; Female; Ganglionic Blockers; Hemodynamics; Muscle Tonus; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Pregnancy; Pregnancy, Animal; Prostaglandins; Rats; Rats, Sprague-Dawley; Vascular Resistance | 1995 |
Interaction between angiotensin II and nitric oxide in control of renal hemodynamics in conscious dogs.
Topics: Angiotensin II; Animals; Arginine; Blood Flow Velocity; Capillary Resistance; Dogs; Glomerular Filtration Rate; Hemodynamics; Kidney; Lithium; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Vasoconstriction | 1994 |
Endothelium-dependent, nitric oxide-mediated inhibition of angiotensin II-induced contractions in rabbit aorta.
Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Arginine; Dose-Response Relationship, Drug; Endothelium, Vascular; Imidazoles; In Vitro Techniques; Indomethacin; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Pyridines; Rabbits | 1994 |
Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Arginine; Biphenyl Compounds; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Imidazoles; Infusions, Intravenous; Losartan; Male; Neuropeptides; Neurotransmitter Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pituitary Adenylate Cyclase-Activating Polypeptide; Propanolamines; Rats; Regional Blood Flow; Sodium Chloride; Tetrazoles; Vasoactive Intestinal Peptide | 1994 |
Acute nitric oxide blockade amplifies the renal vasoconstrictor actions of angiotension II.
Topics: Angiotensin II; Animals; Arginine; Blood Pressure; Glomerular Filtration Rate; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstriction | 1994 |
Angiotensin II: endothelium-derived nitric oxide interaction in conscious rats.
Topics: Angiotensin II; Animals; Arginine; Biphenyl Compounds; Diet, Sodium-Restricted; Endothelium, Vascular; Hemodynamics; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; Tetrazoles | 1994 |
Effects of NG-nitro-L-arginine methyl ester on regional haemodynamic responses to MgSO4 in conscious rats.
Topics: Angiotensin II; Animals; Arginine; Blood Pressure; Drug Interactions; Drug Synergism; Endothelins; Heart Rate; Hemodynamics; Magnesium Sulfate; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Propanolamines; Rats; Receptors, Adrenergic, beta; Renal Artery; Vascular Resistance; Vasodilation | 1994 |
Modulation by the endothelium of sympathetic vasoconstriction in an in vitro preparation of the rat tail artery.
Topics: Angiotensin II; Animals; Arginine; Arteries; Carbachol; Electric Stimulation; Endothelium, Vascular; In Vitro Techniques; Male; Methylene Blue; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Rats; Rats, Wistar; Sympathetic Nervous System; Tail; Vasoconstriction | 1994 |
Altered renal vascular responses in the aging rat kidney.
Topics: Aging; Angiotensin II; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Endothelins; Glomerular Filtration Rate; Imidazoles; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrazoles | 1994 |
Angiotensin II 1 receptor-mediated contraction of pulmonary artery and its modulation by prolylcarboxypeptidase.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Biphenyl Compounds; Carboxypeptidases; Dogs; Endothelium, Vascular; Imidazoles; In Vitro Techniques; Isometric Contraction; Losartan; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Protease Inhibitors; Pulmonary Artery; Pyridines; Receptors, Angiotensin; Tetrazoles | 1994 |
Pregnancy-induced hypertension in rats with early adriamycin nephropathy.
Topics: Angiotensin II; Animals; Arginine; Blood Pressure; Doxorubicin; Female; Hypertension; Nephrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylacetates; Pregnancy; Pregnancy Complications, Cardiovascular; Rats; Rats, Wistar; Receptors, Thromboxane; Sulfonamides | 1994 |
Cerebrovascular autoregulation in response to hypertension induced by NG-nitro-L-arginine methyl ester.
Topics: Angiotensin II; Animals; Arginine; Autoradiography; Blood Pressure; Brain; Cerebrovascular Circulation; Glucose; Homeostasis; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley | 1994 |
[Role of endothelium-derived nitric oxide in mediating the natriuretic response to acute extracellular volume expansion].
Topics: Angiotensin II; Animals; Arginine; Diuresis; Extracellular Space; Isotonic Solutions; Male; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Sodium Chloride | 1994 |
Glomerular prostaglandins modulate vascular reactivity of the downstream efferent arterioles.
Topics: Angiotensin II; Animals; Arginine; Arterioles; Dose-Response Relationship, Drug; Indomethacin; Kidney Glomerulus; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Prostaglandins; Rabbits; Vascular Resistance | 1994 |
Angiotensin II and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension.
Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Glomerular Filtration Rate; Hematocrit; Hypertension; Imidazoles; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Angiotensin; Reference Values; Regional Blood Flow; Renal Circulation; Tetrazoles; Vascular Resistance | 1994 |
Effects of nitric oxide synthesis blockade and angiotensin II on blood flow and spontaneous vasomotion in the rat cerebral microcirculation.
Topics: Angiotensin II; Animals; Arginine; Blood Pressure; Cerebral Cortex; Injections, Intravenous; Laser-Doppler Flowmetry; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasoconstriction; Vasodilation | 1993 |
Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
Topics: Adenine; Adenosine; Angiotensin II; Animals; Arginine; Arginine Vasopressin; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Imidazoles; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Purinergic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Regional Blood Flow; Renal Circulation; Serotonin; Tetrazoles; Thromboxane A2; Vascular Resistance; Vasoconstriction | 1993 |
Angiotensin II: nitric oxide interaction and the distribution of blood flow.
Topics: Angiotensin II; Animals; Arginine; Biphenyl Compounds; Blood Circulation; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Tetrazoles; Vascular Resistance | 1993 |
Renal nitric oxide and angiotensin II interaction in renovascular hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arginine; Biphenyl Compounds; Endothelium, Vascular; Hemodynamics; Hypertension, Renovascular; Imidazoles; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrazoles | 1993 |
Magnesium sulphate reverses the carotid vasoconstriction caused by endothelin-I, angiotensin II and neuropeptide-Y, but not that caused by NG-nitro-L-arginine methyl ester, in conscious rats.
Topics: Angiotensin II; Animals; Arginine; Calcitonin Gene-Related Peptide; Carotid Arteries; Dose-Response Relationship, Drug; Endothelins; Magnesium; Magnesium Sulfate; Male; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred Strains; Vasoconstriction | 1993 |
Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Diuresis; Glomerular Filtration Rate; Imidazoles; Kidney; Losartan; Male; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrazoles; Time Factors | 1993 |
Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole.
Topics: Angiotensin II; Animals; Arginine; Arterioles; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney; Kinetics; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroarginine; Norepinephrine; Perfusion; Rabbits; Vasoconstriction | 1993 |
Angiotensin II-induced endothelium-dependent relaxation of fowl aorta.
Topics: Acetylcholine; Aging; Angiotensin II; Animals; Aorta; Arginine; Calcium; Endothelium, Vascular; Female; Gossypol; Hydroquinones; NG-Nitroarginine Methyl Ester; Poultry; Vasoconstrictor Agents; Vasodilation | 1993 |
Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade.
Topics: Angiotensin II; Animals; Arginine; Biphenyl Compounds; Diet, Sodium-Restricted; Electrolytes; Hemodynamics; Hypertension; Imidazoles; Losartan; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Time Factors | 1993 |
Role of nitric oxide in long-term angiotensin II-induced renal vasoconstriction.
Topics: Acetylcholine; Angiotensin II; Animals; Arginine; Blood Pressure; Dogs; Extracellular Space; Glomerular Filtration Rate; Heart Rate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Renal Circulation; Renin; Sodium; Time Factors; Vascular Resistance; Vasoconstriction | 1993 |
Nitric oxide and the depressor response to angiotensin blockade in hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Coarctation; Arginine; Biphenyl Compounds; Blood Pressure; Hypertension; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ramipril; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles; Vasoconstrictor Agents | 1996 |
Role of nitric oxide in short-term and prolonged effects of angiotensin II on renal hemodynamics.
Topics: Acetylcholine; Angiotensin II; Animals; Arginine; Hemodynamics; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Renal Circulation; Time Factors; Vascular Resistance; Vasodilation | 1996 |
The angiotensin receptor antagonist 2-ethoxy-1-[[2'-(1H- tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV11974) attenuates the tubuloglomerular feedback response during NO synthase blockade in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Feedback; Hemodynamics; Homeostasis; Kidney Glomerulus; Kidney Tubules; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Tetrazoles | 1996 |
Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin.
Topics: Angiotensin II; Animals; Arginine; Bradykinin; Bradykinin Receptor Antagonists; Collagen; Cyclooxygenase Inhibitors; Fibrosis; Indomethacin; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prostaglandins; Rats; Rats, Sprague-Dawley | 1996 |
Inhibition of nitric oxide synthase attenuates osmotic thirst in the rat.
Topics: Angiotensin II; Animals; Arginine; Drinking Behavior; Enzyme Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Osmotic Pressure; Rats; Rats, Wistar; Thirst; Water-Electrolyte Balance | 1995 |
Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Arginine; Biphenyl Compounds; Cell Division; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; Infusion Pumps, Implantable; Losartan; Macrophages; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Tetrazoles | 1996 |
A study of angiotensin II receptors after chronic inhibition of nitric oxide synthase in the spontaneously hypertensive rat.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Enzyme Inhibitors; Female; Hypertension; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Time Factors; Uterus | 1996 |
Effect of nitric oxide inhibition on secretion of atrial natriuretic factor in isolated rat heart.
Topics: Acetylcholine; Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; In Vitro Techniques; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley | 1996 |
Role of ANG II in hypertension produced by chronic inhibition of nitric oxide synthase in conscious rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Enalapril; Hypertension; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reference Values; Tetrazoles; Time Factors | 1996 |
Angiotensin II-induced renal responses in anesthetized rabbits: effects of N omega-nitro-L-arginine methyl ester and losartan.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Enzyme Inhibitors; Hemodynamics; Imidazoles; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rabbits; Receptors, Angiotensin; Tetrazoles; Vasoconstrictor Agents | 1996 |
Chronic inhaled nitric oxide: effects on pulmonary vascular endothelial function and pathology in rats.
Topics: Administration, Inhalation; Air Pressure; Angiotensin II; Animals; Arginine; Blood Pressure; Endothelium, Vascular; Enzyme Inhibitors; Hypoxia; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Vasodilation; Ventricular Function, Right | 1996 |
Angiotensin II stimulates production of nitric oxide in guinea pig airways via AT1 receptor activation.
Topics: Angiotensin II; Animals; Arginine; Bronchi; Bronchoconstriction; Guinea Pigs; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptors, Angiotensin | 1995 |
Modulation by nitric oxide and prostaglandin of the renal vascular response to angiotensin II (3-8).
Topics: Angiotensin II; Animals; Cyclooxygenase Inhibitors; Drug Interactions; Hypertension; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Vasoconstriction | 1996 |
Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes.
Topics: Angiotensin II; Animals; Arginine; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Glomerular Filtration Rate; Hemodynamics; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Renal Circulation; Time Factors | 1996 |
Nitric oxide and drinking behaviour.
Topics: Angiotensin II; Animals; Arginine; Dose-Response Relationship, Drug; Drinking; Drinking Behavior; Enzyme Inhibitors; Injections, Intraventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 1996 |
Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arteries; Biphenyl Compounds; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Indomethacin; Losartan; Male; NG-Nitroarginine Methyl Ester; Norepinephrine; Pyridines; Rats; Rats, Sprague-Dawley; Tetrazoles; Vasoconstriction | 1996 |
Nitric oxide and angiotensin II regulation of renal hemodynamics in the developing piglet.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Hemodynamics; Kidney; NG-Nitroarginine Methyl Ester; Nicotinic Acids; Nitric Oxide; Regional Blood Flow; Renin; Swine; Tetrazoles; Vascular Resistance | 1996 |
[Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Heart Rate; Hypertension; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles | 1996 |
Effect of angiotensin II on the apical K+ channel in the thick ascending limb of the rat kidney.
Topics: Angiotensin II; Animals; Cell Membrane; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Loop of Henle; Naphthalenes; NG-Nitroarginine Methyl Ester; Patch-Clamp Techniques; Penicillamine; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Sodium | 1996 |
Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF).
Topics: Angiotensin II; Animals; Aorta; Arginine; Blood Pressure; Brain; Creatinine; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Hypertension; Hypothalamus; Kidney Failure, Chronic; Locus Coeruleus; Male; Medulla Oblongata; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Norepinephrine; Paraventricular Hypothalamic Nucleus; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sympathetic Nervous System; Synaptic Transmission; Transcription, Genetic | 1997 |
Role of nitric oxide in modulating the chronic renal and arterial pressure responses to angiotensin II.
Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Chronic Disease; Dogs; Enzyme Inhibitors; Glomerular Filtration Rate; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Renal Plasma Flow; Vasoconstrictor Agents | 1997 |
Vasoactive intestinal peptide causes nitric oxide-dependent pulmonary vasodilation in isolated rat lung.
Topics: Angiotensin II; Animals; Enzyme Inhibitors; In Vitro Techniques; Lung; Male; Meclofenamic Acid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Perfusion; Pulmonary Circulation; Rats; Rats, Inbred BUF; Vasoactive Intestinal Peptide; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 1997 |
Role of nitric oxide in impaired coronary circulation and improvement by angiotensin II receptor antagonist in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Coronary Circulation; Enzyme Inhibitors; Hypertension; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1995 |
Inhibition of nitric oxide synthase causes cardiac phenotypic modulation in rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blotting, Northern; Collagen; Contractile Proteins; DNA Probes; Enzyme Inhibitors; Gene Expression Regulation; Heart; Imidazoles; Losartan; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Phenotype; Rats; Rats, Wistar; RNA; Tetrazoles | 1997 |
Effects of aminoguanidine and N(G)-nitro-L-arginine methyl ester on vascular responses of aortae and lungs from streptozotocin-diabetic rats.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Diabetes Mellitus, Experimental; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Guanidines; Lung; Male; NG-Nitroarginine Methyl Ester; Phenylephrine; Rats; Rats, Wistar; Vasodilation | 1997 |
The effect of chronic nitric oxide synthesis inhibition on blood pressure and angiotensin II responsiveness in the pregnant rat.
Topics: Angiotensin II; Animals; Blood Pressure; Enzyme Inhibitors; Female; Guanidines; Heart Rate; Hematocrit; Kinetics; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitrites; Pregnancy; Proteinuria; Rats; Rats, Inbred WKY | 1997 |
Effects of 17 beta-oestradiol on vascular responses in the in situ blood-perfused mesentery of Wistar-Kyoto rats.
Topics: Angiotensin II; Animals; Drug Synergism; Estradiol; Female; Mesentery; NG-Nitroarginine Methyl Ester; Norepinephrine; Perfusion; Pregnancy; Rats; Rats, Inbred WKY; Splanchnic Circulation; Vasoconstriction | 1997 |
Verapamil abolishes the preglomerular response to ANG II during intrarenal nitric oxide synthesis inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Captopril; Dogs; Enzyme Inhibitors; Kidney; Kidney Glomerulus; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Regional Blood Flow; Vascular Resistance; Verapamil | 1997 |
Possible participation of nitric oxide in the increase of norepinephrine release caused by angiotensin peptides in rat atria.
Topics: Angiotensin I; Angiotensin II; Animals; Drug Interactions; Electrophysiology; Enzyme Inhibitors; Female; Heart Atria; Heart Rate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Peptide Fragments; Rats; Rats, Wistar; Sympathomimetics | 1997 |
Interaction of nitric oxide and the renin angiotensin system in renal hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Enzyme Inhibitors; Heart Rate; Hypertension, Renovascular; Imidazoles; In Vitro Techniques; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Tetrazoles; Vasoconstrictor Agents | 1997 |
The increase in blood pressure induced by inhibition of nitric oxide synthase in anesthetized Wistar rats is inversely related to basal blood pressure value.
Topics: Aging; Anesthesia, General; Angiotensin II; Animals; Blood Pressure; Enzyme Inhibitors; Ganglionic Blockers; Hexamethonium Compounds; Male; Methylguanidine; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Vasoconstrictor Agents | 1997 |
Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.
Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Captopril; Endothelium, Vascular; Hypertension; Imidazoles; In Vitro Techniques; Losartan; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Superoxide Dismutase; Tetrazoles; Vasoconstriction; Vasodilation | 1997 |
The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Cyclic GMP; Enzyme Inhibitors; Extracellular Space; Female; Imidazoles; Indazoles; Kidney; Losartan; Microdialysis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; Sodium; Tetrazoles | 1997 |
Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Albuterol; Alprostadil; Analysis of Variance; Angiotensin II; Animals; Benzopyrans; Blood Pressure; Bradykinin; Cats; Cromakalim; Endothelium, Vascular; Female; Glyburide; Heart Rate; Hindlimb; Hydrazines; Isradipine; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitrogen Oxides; Nitroprusside; Norepinephrine; Penicillamine; Prostaglandin Endoperoxides, Synthetic; Pyrroles; S-Nitroso-N-Acetylpenicillamine; Substance P; Tetraethylammonium; Tetraethylammonium Compounds; Thromboxane A2; Vasoactive Intestinal Peptide; Vasodilation; Vasodilator Agents | 1997 |
Effect of angiotensin II on corpus cavernosum smooth muscle in relation to nitric oxide environment: in vitro studies in canines.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dogs; Electric Stimulation; Enzyme Inhibitors; Losartan; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Penis; Phenylephrine | 1997 |
Reduced sensitivity of the renal circulation to angiotensin II in pregnant rats.
Topics: Angiotensin II; Animals; Female; Glomerular Filtration Rate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Renal Circulation | 1997 |
Abnormal endothelium-dependent responses in early radiation nephropathy.
Topics: Acetylcholine; Angiotensin II; Animals; Blood Pressure; Endothelium, Vascular; Indomethacin; Kidney; NG-Nitroarginine Methyl Ester; Rats; Renal Circulation; Vasodilation | 1997 |
Role of endothelium and nitric oxide in the in vitro response of equine colonic venous rings to vasoconstrictor agents.
Topics: Analysis of Variance; Angiotensin II; Animals; Colon; Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; Histamine; Horses; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Sensitivity and Specificity; Thromboxane B2; Vasoconstriction; Vasoconstrictor Agents; Vasopressins; Veins | 1997 |
Arterial function in mineralocorticoid-NaCl hypertension: influence of angiotensin-converting enzyme inhibition.
Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension; Isoquinolines; Male; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Quinapril; Rats; Rats, Inbred WKY; Sodium Chloride; Tetrahydroisoquinolines | 1997 |
Interactions between nitric oxide and angiotensin II on renal cortical and papillary blood flow.
Topics: Angiotensin II; Animals; Blood Pressure; Denervation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Homeostasis; Imidazoles; Kidney; Kidney Cortex; Kidney Medulla; Laser-Doppler Flowmetry; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyridines; Rats; Rats, Wistar; Regional Blood Flow; Tetrazoles; Valine; Valsartan | 1997 |
Effect of interactions between nitric oxide and angiotensin II on pressure diuresis and natriuresis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Diuresis; Glomerular Filtration Rate; Imidazoles; Kidney; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pressure; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Renal Circulation; Tetrazoles; Valine; Valsartan | 1997 |
Postnatal development of vascular resistance of the rabbit isolated perfused kidney: modulation by nitric oxide and angiotensin II.
Topics: Age Factors; Angiotensin II; Animals; Animals, Newborn; Enzyme Inhibitors; In Vitro Techniques; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide; Perfusion; Rabbits; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 1997 |
Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin Receptor Antagonists; Cardiovascular Physiological Phenomena; Diet, Sodium-Restricted; Enzyme Inhibitors; Kidney; Mice; Myocardium; NG-Nitroarginine Methyl Ester; Nicotinic Acids; Phenotype; Receptors, Angiotensin; Receptors, Bradykinin; Renin; RNA, Messenger; Species Specificity; Tetrazoles | 1997 |
Dilatation by angiotensin II of the rat femoral arterial bed in vivo via pressure/flow-induced release of nitric oxide and prostaglandins.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Bosentan; Female; Femoral Artery; Hexamethonium; Indomethacin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prazosin; Propranolol; Prostaglandins; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sulfonamides; Telmisartan; Vasodilation | 1997 |
AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Renal Circulation; Vascular Resistance; Vasoconstriction | 1997 |
Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation.
Topics: Angiotensin II; Animals; In Vitro Techniques; Kidney Cortex; Kidney Medulla; Male; Microdialysis; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renal Circulation | 1998 |
AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cerebrovascular Disorders; Cyclic GMP; Hypertension; Imidazoles; Losartan; Male; Minoxidil; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Pyridines; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reference Values | 1998 |
Vascular endothelial growth factor mRNA in pericytes is upregulated by phorbol myristate acetate.
Topics: Angiotensin II; Animals; Antibodies, Monoclonal; Arterioles; Cattle; Endothelial Growth Factors; Humans; Immunomagnetic Separation; Lymphokines; Mice; NG-Nitroarginine Methyl Ester; Retinal Vessels; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Arginine; Bradykinin; Calcium; Calmodulin; Cells, Cultured; Endothelium, Vascular; Losartan; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Oxidants; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sulfonamides | 1998 |
Angiotensin II-nitric oxide interaction on sympathetic outflow in conscious rabbits.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Consciousness; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sympathetic Nervous System | 1998 |
Angiotensin II and cardiovascular chemoreflex responses to acute hypoxia in late gestation fetal sheep.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Carotid Arteries; Carotid Sinus; Chemoreceptor Cells; Denervation; Female; Femoral Artery; Fetal Blood; Fetal Hypoxia; Fetus; Gestational Age; Heart Rate, Fetal; Hemodynamics; NG-Nitroarginine Methyl Ester; Pregnancy; Reflex; Regional Blood Flow; Sheep; Vascular Resistance | 1998 |
A nitric oxide donor NOC 7 suppresses renal responses induced by norepinephrine and angiotensin II in the NO-depleted denevated rabbit kidney.
Topics: Angiotensin II; Animals; Denervation; Enzyme Inhibitors; Kidney; Kidney Function Tests; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Rabbits; Renal Circulation; Triazenes; Vasoconstrictor Agents | 1998 |
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Apoptosis; Arginine; Biotin; Cyclosporine; Deoxyuracil Nucleotides; DNA Fragmentation; Enzyme Inhibitors; Fibrosis; Hydralazine; Immunosuppressive Agents; Ischemia; Kidney; Losartan; Macrophages; Male; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Staining and Labeling | 1998 |
Hemodynamic effect of 17 beta-estradiol in absence of NO in ovariectomized rats: role of angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiac Output; Enzyme Inhibitors; Estradiol; Female; Hemodynamics; Losartan; NG-Nitroarginine Methyl Ester; Nitric Oxide; Ovariectomy; Rats; Rats, Sprague-Dawley; Vascular Resistance | 1998 |
Role of AT1 receptors in the renal papillary effects of acute and chronic nitric oxide inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Enzyme Inhibitors; Kidney Medulla; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow | 1998 |
Effect of chronic nitric oxide deficiency on angiotensin II-induced hypertrophy of rat basilar artery.
Topics: Analysis of Variance; Angiotensin II; Animals; Basilar Artery; Blood Pressure; Body Weight; Enzyme Inhibitors; Hypertrophy; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Organ Size; Rats; Rats, Inbred WKY; Systole; Vasoconstrictor Agents; Weight Gain | 1998 |
Evidence that angiotensin II, endothelins and nitric oxide regulate mitogen-activated protein kinase activity in rat aorta.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Calcium-Calmodulin-Dependent Protein Kinases; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Peptides, Cyclic; Rats; Rats, Wistar | 1998 |
Evaluation of the renin-angiotensin system in a congenic renin Dahl salt-sensitive rat.
Topics: Adrenal Glands; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Enzyme Inhibitors; Hypertension; Kidney; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; RNA, Messenger; Saralasin; Sodium | 1997 |
Role of nitric oxide in angiotensin IV-induced increases in cerebral blood flow.
Topics: Angiotensin II; Animals; Brain; Enzyme Inhibitors; Female; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 1998 |
Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
Topics: Angiotensin II; Animals; Enzyme Inhibitors; Indomethacin; Infusions, Intra-Arterial; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prostaglandins; Rats; Rats, Wistar; Renal Artery | 1998 |
Nitric oxide release as an essential mitigating step in tubuloglomerular feedback: observations during intrarenal nitric oxide clamp.
Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Enalapril; Enzyme Inhibitors; Feedback; Glomerular Filtration Rate; Kidney Glomerulus; Kidney Tubules; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pressoreceptors; Rats; Rats, Sprague-Dawley; Reference Values; Renal Circulation | 1998 |
Role of eicosanoids in renal angiotensin II vasoconstriction during nitric oxide blockade.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Angiotensin II; Animals; Eicosanoids; Enzyme Inhibitors; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Culture Techniques; Prostaglandins; Rats; Rats, Wistar; Renal Circulation; Vascular Resistance; Vasoconstriction | 1998 |
Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism.
Topics: Angiotensin II; Animals; Aorta; Arteritis; Biphenyl Compounds; Blotting, Western; Enzyme Inhibitors; Immunohistochemistry; Intercellular Adhesion Molecule-1; Irbesartan; Macrophages; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Polymerase Chain Reaction; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Vascular Cell Adhesion Molecule-1 | 1998 |
Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chronic Disease; Denervation; Enzyme Inhibitors; Hypertension; Injections, Intravenous; Injections, Intraventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phentolamine; Rats; Rats, Wistar; Sinoatrial Node; Tetrazoles | 1998 |
Brief pharmacological intervention in experimental radiation nephropathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enzyme Inhibitors; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Radiation Injuries, Experimental; Rats; Whole-Body Irradiation | 1998 |
Factors involved in the effects of losartan on endothelial dysfunction induced by aging in SHR.
Topics: Acetylcholine; Aging; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Kidney; Losartan; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitrites; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasoconstrictor Agents; Vasodilation | 1998 |
The effect of prolonged inhaled nitric oxide on pulmonary vasoconstriction in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Angiotensin II; Animals; Hypoxia; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation.
Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Enzyme Activation; Glutamyl Aminopeptidase; Indomethacin; Methionyl Aminopeptidases; Methylene Blue; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pulmonary Artery; Receptors, Angiotensin; Swine; Vasodilation | 1998 |
Guinea pig airway hyperresponsiveness induced by blockade of the angiotensin II type 1 receptor. Role for endogenous nitric oxide.
Topics: Acetylcholine; Airway Obstruction; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Bronchi; Bronchial Hyperreactivity; Bronchoconstriction; Cells, Cultured; Enzyme Inhibitors; Epithelial Cells; Guinea Pigs; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pyridines | 1999 |
Angiotensin II regulates choroid plexus blood flow by interacting with the sympathetic nervous system and nitric oxide.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Choroid Plexus; Enzyme Inhibitors; Ganglionectomy; Infusions, Intravenous; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Superior Cervical Ganglion; Sympathetic Nervous System; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Nitric oxide participates in the renal vasodilatory effect of candesartan in anesthetized rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Tetrazoles; Vasodilation | 1999 |
[Renal hemodynamic interactions of nitric oxide and angiotensin II].
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcium; Enzyme Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Renal Circulation | 1998 |
Compartmentalization of extracellular cGMP determines absorptive or secretory responses in the rat jejunum.
Topics: Angiotensin II; Animals; Arginine; Chlorides; Cyclic GMP; Diet, Sodium-Restricted; Enterotoxins; Imidazoles; Intestinal Absorption; Jejunum; Male; Microscopy, Fluorescence; NG-Nitroarginine Methyl Ester; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Sodium; Water | 1999 |
Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Cardiomegaly; Desoxycorticosterone; Endothelium, Vascular; Hypertension; In Vitro Techniques; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organ Size; Rats; Rats, Sprague-Dawley; Sodium Chloride; Splanchnic Circulation | 1998 |
Local renal medullary L-NAME infusion enhances the effect of long-term angiotensin II treatment.
Topics: Angiotensin II; Animals; Blood Pressure; Drug Synergism; Hypertension; Infusions, Intravenous; Infusions, Parenteral; Kidney Cortex; Kidney Medulla; Nephrectomy; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renal Circulation; Time Factors | 1999 |
Relaxin is a potent renal vasodilator in conscious rats.
Topics: Angiotensin II; Animals; Cyclic GMP; Female; Hematocrit; Humans; Infusions, Intra-Arterial; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide; Osmolar Concentration; Ovariectomy; Rats; Rats, Long-Evans; Recombinant Proteins; Relaxin; Swine; Vasodilator Agents | 1999 |
Effects of sodium depletion on the role of AT1- and alpha-adrenergic receptors in the regulation of forearm vascular tone in humans.
Topics: Adrenergic alpha-Antagonists; Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Forearm; Furosemide; Humans; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Plethysmography; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Sodium; Sympathetic Nervous System; Vasoconstrictor Agents; Vasomotor System | 1999 |
Angiotensin II-stimulated nitric oxide release from porcine pulmonary endothelium is mediated by angiotensin IV.
Topics: Angiotensin II; Animals; Bradykinin; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Losartan; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pulmonary Artery; Reference Values; Swine; Vasoconstrictor Agents | 1999 |
Role of insulin preincubation in the contractile reactivity of rat aortic rings.
Topics: Angiotensin II; Animals; Aorta; Arginine Vasopressin; Endothelin-1; Enzyme Inhibitors; Epoprostenol; Indomethacin; Insulin; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Vasoconstriction | 1998 |
Endothelial dysfunction in the aorta of transgenic rats harboring the mouse Ren-2 gene.
Topics: Acetylcholine; Angiotensin II; Animals; Animals, Genetically Modified; Aorta; Blood Pressure; Body Weight; Endothelin-1; Endothelins; Endothelium, Vascular; Hypertension; Male; Mice; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Norepinephrine; Protein Precursors; Rats; Rats, Sprague-Dawley; Renin | 1999 |
Role of angiotensin II in modulating the hemodynamic effects of nitric oxide synthesis inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Capillary Permeability; Enzyme Inhibitors; Extravasation of Diagnostic and Therapeutic Materials; Female; Hemodynamics; Laser-Doppler Flowmetry; Losartan; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley | 1999 |
Regional blood flow responses to acute ANG II infusion: effects of nitric oxide synthase inhibition.
Topics: Angiotensin II; Animals; Autopsy; Blood Pressure; Drug Synergism; Enzyme Inhibitors; Hemodynamics; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Regional Blood Flow; Reproducibility of Results; Vasoconstriction | 1999 |
Interactions between angiotensin II and nitric oxide during exercise in normal and heart failure rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Female; Heart Diseases; Heart Rate; Losartan; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Physical Conditioning, Animal; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow | 1999 |
The impact of vasoactive peptides on nitric oxide production in cultured sympathetic neurons.
Topics: Angiotensin II; Animals; Arginine; Calcium; Cells, Cultured; Chick Embryo; Endothelin-1; Enzyme Inhibitors; Fluorescent Dyes; Microelectrodes; Microscopy, Fluorescence; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Norepinephrine; Penicillamine; S-Nitroso-N-Acetylpenicillamine; Sympathetic Nervous System | 1999 |
Role of shear stress in nitric oxide-dependent modulation of renal angiotensin II vasoconstriction.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Viscosity; Enzyme Inhibitors; Hemorheology; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Stress, Physiological; Vasoconstrictor Agents | 1999 |
Role of angiotensin II in the renal effects induced by nitric oxide and prostaglandin synthesis inhibition.
Topics: Analysis of Variance; Angiotensin II; Animals; Cyclooxygenase Inhibitors; Dogs; Glomerular Filtration Rate; Hypertension, Renal; Kidney; Meclofenamic Acid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prostaglandin Antagonists; Prostaglandins; Renal Circulation; Renin-Angiotensin System; Vasoconstriction | 1997 |
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation.
Topics: Actins; Amiloride; Angiotensin II; Animals; Aorta; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cell Membrane; Cyclic GMP; Endothelium, Vascular; Imidazoles; Kinins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Promoter Regions, Genetic; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Fusion Proteins; Tunica Media; Vasoconstriction; Vasodilation | 1999 |
The contribution of nitric oxide and endothelins to angiotensin: II. Evoked responses in the rat isolated uterus smooth muscle.
Topics: Angiotensin II; Animals; Azepines; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Female; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; Rats; Rats, Wistar; Receptor, Endothelin A; Uterus | 1999 |
Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cromakalim; Cyclooxygenase Inhibitors; Diclofenac; Hypertension; In Vitro Techniques; Isoproterenol; Losartan; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Rats; Rats, Wistar; Vasodilator Agents | 1999 |
Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Endothelin-1; Enzyme Inhibitors; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 1999 |
Effect of injection of L-NAME on drinking response.
Topics: Angiotensin II; Animals; Drinking; Drinking Behavior; Enzyme Inhibitors; Lateral Ventricles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Subfornical Organ; Vasoconstrictor Agents | 1999 |
Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism.
Topics: Angiotensin I; Angiotensin II; Animals; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hemodynamics; Hypertension; Indans; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Vasoconstrictor Agents | 1999 |
Interaction between nitric oxide and endogenous vasoconstrictors in control of renal blood flow.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dogs; Drug Interactions; Endothelin Receptor Antagonists; Enzyme Inhibitors; Female; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Penicillamine; Phenylpropionates; Pyrimidines; Receptor, Endothelin A; Renal Circulation; Vasoconstrictor Agents | 1999 |
Involvement of superoxide in acute reaction of angiotensin II in mesenteric microcirculation.
Topics: Angiotensin II; Animals; Arginine; Enzyme Inhibitors; Imidazoles; Luminescent Measurements; Male; Mesenteric Arteries; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Oxygen; Pyrazines; Rats; Rats, Inbred WKY; Splanchnic Circulation; Superoxide Dismutase; Superoxides; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Homocyst(e)ine impairs endocardial endothelial function.
Topics: Angiotensin II; Animals; Calcium Chloride; Dose-Response Relationship, Drug; Endothelins; Endothelium; Heart Ventricles; Homocysteine; In Vitro Techniques; Isometric Contraction; Male; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred WKY; Time Factors; Ventricular Function, Left; Ventricular Function, Right | 1999 |
Pressor and mesenteric arterial hyporesponsiveness to angiotensin II is an early event in haemorrhagic hypotension in anaesthetised rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Benzimidazoles; Benzoates; Blood Pressure; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Glyburide; Hemodynamics; Indomethacin; Male; Mesenteric Artery, Superior; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Shock, Hemorrhagic; Telmisartan; Time Factors; Vasoconstrictor Agents | 1999 |
Calcium-mediated mechanisms of eicosapentaenoic acid-induced relaxation in hypertensive rat aorta.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Calcium; Cells, Cultured; Eicosapentaenoic Acid; Endothelium, Vascular; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Hypertension; Inositol 1,4,5-Trisphosphate; Intracellular Fluid; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Norepinephrine; Potassium Channels; Rats; Rats, Inbred SHR; Vasoconstrictor Agents; Vasodilation | 1999 |
Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats.
Topics: Angiotensin II; Animals; Chemokine CCL2; Coronary Vessels; Inflammation; Male; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptidyl-Dipeptidase A; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Superoxides | 2000 |
Aging is associated with endothelial dysfunction in the human forearm vasculature.
Topics: Acetylcholine; Adolescent; Adult; Aged; Aged, 80 and over; Aging; Angiotensin II; Brachial Artery; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; Plethysmography; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents; Vasomotor System | 2000 |
Hemodynamic effects of nitric oxide synthase inhibition at steady state and following tumor necrosis factor-alpha-induced myodepression.
Topics: Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Dogs; Enzyme Inhibitors; Female; Hemodynamics; Male; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Stroke Volume; Tumor Necrosis Factor-alpha; Ventricular Pressure | 1999 |
Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterioles; Dose-Response Relationship, Drug; Enzyme Inhibitors; Imidazoles; Male; Miconazole; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasoconstriction; Vasoconstrictor Agents | 2000 |
Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Calcium; Cells, Cultured; Collagen; Felodipine; Fluorescent Dyes; Fura-2; Glutathione; Homocysteine; Homocystine; Kinetics; Muscle, Smooth, Vascular; Neomycin; NG-Nitroarginine Methyl Ester; Pravastatin; Rats; Second Messenger Systems; Staurosporine; Tetradecanoylphorbol Acetate; Thapsigargin | 2000 |
Nitric oxide modulates angiotensin II-induced drinking behavior in the near-term ovine fetus.
Topics: Angiotensin II; Animals; Behavior, Animal; Deglutition; Drinking Behavior; Enzyme Inhibitors; Female; Fetus; Gestational Age; Hemodynamics; Injections, Intraventricular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pregnancy; Sheep | 2000 |
Onset of glomerular hypertension with aging precedes injury in the spontaneously hypertensive rat.
Topics: Aging; Angiotensin II; Animals; Endothelin-1; Enzyme Inhibitors; Hemodynamics; Hypertension, Renal; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Punctures; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation | 2000 |
Short treatments of normotensive and hypertensive rats by angiotensin II and nitric oxide inhibitor induce an increase of noradrenaline sensitivity in isolated vena portae preparations.
Topics: Angiotensin II; Animals; Blood Pressure; Bradykinin; Drug Interactions; Ergotamine; Hypertension; In Vitro Techniques; Male; Minoxidil; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Portal Vein; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstriction | 2000 |
Angiotensin II induces contraction and proliferation of human hepatic stellate cells.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Cell Division; Cell Size; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Humans; Imidazoles; Indomethacin; Iodine Radioisotopes; Liver; Losartan; Mitogen-Activated Protein Kinases; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Penicillamine; Pyridines; Radioligand Assay; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium Nitrite; Thymidine; Vasoconstrictor Agents | 2000 |
Nitric oxide and prostanoid-dependent relaxation induced by angiotensin II in the isolated precontracted mouse tracheal muscle and the role of potassium channels.
Topics: Angiotensin II; Animals; Aspirin; Carbachol; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Male; Mice; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Potassium Channels; Prostaglandins; Trachea | 2000 |
Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Basilar Artery; Blood Pressure; Brain; Enalapril; Enzyme Inhibitors; Hypertension; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR; Stroke; Tetrazoles; Valine; Valsartan; Ventricular Function, Left | 2000 |
Cardiovascular responses to glutamate and angiotensin II in ventrolateral medulla of hypertension induced by chronic inhibition of nitric oxide.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiovascular System; Enzyme Inhibitors; Glutamic Acid; Heart Rate; Hypertension; Male; Medulla Oblongata; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Time Factors | 2000 |
Indomethacin prevents the L-NAME-induced increase in plasma levels of oxytocin in dehydrated rats.
Topics: Angiotensin II; Animals; Dehydration; Hypothalamo-Hypophyseal System; Indomethacin; Injections, Intraventricular; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxytocin; Prostaglandins; Rats; Rats, Sprague-Dawley; Vasopressins; Water Deprivation; Water-Electrolyte Balance | 2000 |
Induction of angiotensin II subtype 2 receptor-mediated blood pressure regulation in synthetic diet-fed rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Captopril; Cardiac Glycosides; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epinephrine; Gene Expression; Imidazoles; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Norepinephrine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Signal Transduction; Vasoconstrictor Agents; Vasodilation; Weight Gain | 2000 |
H+-ATPase activity on unilateral ureteral obstruction: interaction of endogenous nitric oxide and angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Enzyme Activation; Enzyme Inhibitors; Female; Kidney Medulla; Losartan; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Proton-Translocating ATPases; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; Ureteral Obstruction | 2000 |
Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiomyopathies; Enzyme Inhibitors; Eplerenone; Hormone Antagonists; Kidney; Male; Myocardium; Necrosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Renal Artery; Renin; Sodium Chloride; Spironolactone; Vascular Diseases | 2000 |
Angiotensin IV-mediated pulmonary artery vasorelaxation is due to endothelial intracellular calcium release.
Topics: Angiotensin II; Animals; Calcium; Cell Membrane; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Enzyme Activation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organ Culture Techniques; Pulmonary Artery; Receptors, Angiotensin; Swine; Vasodilation | 2000 |
Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Enzyme Inhibitors; Imidazoles; Immunohistochemistry; Male; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Olmesartan Medoxomil; Oxidative Stress; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Superoxides; Systole; Tetrazoles; Transcription Factor AP-1 | 2000 |
New method for imaging innervation of the renal preglomerular vasculature. Alterations in hypertensive rats.
Topics: Adrenergic Fibers; Angiotensin II; Animals; Arteries; Disease Models, Animal; Hypertension; Immunohistochemistry; Kidney; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Synaptophysin | 2000 |
Adenosine signaling in outer medullary descending vasa recta.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Adenosine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angiotensin II; Animals; Calcimycin; Calcium; Colforsin; Cyclic AMP; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Female; Ionophores; Kidney Medulla; Kinetics; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Signal Transduction; Thromboxane A2; Vasodilation | 2001 |
Effects of nitric oxide synthase inhibition on angiotensin receptors and metabolism in the pregnant hypertensive rat.
Topics: Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Female; Hypertension; Metabolic Clearance Rate; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria; Random Allocation; Rats; Rats, Inbred SHR; Receptors, Angiotensin | 2001 |
Angiotensin II increases neurogenic nitric oxide metabolism in mesenteric arteries from hypertensive rats.
Topics: Angiotensin II; Animals; Electric Stimulation; Hypertension; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred SHR; Saralasin; Superoxide Dismutase; Superoxides | 2001 |
Role of nitric oxide on atrial natriuretic peptide release induced by angiotensin II in superfused rat atrial tissue.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Heart Atria; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Perfusion; Radioimmunoassay; Rats; Rats, Sprague-Dawley | 2001 |
Acute pressor actions of ouabain do not enhance the actions of phenylephrine or norepinephrine in anesthetized rats.
Topics: Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; NG-Nitroarginine Methyl Ester; Norepinephrine; Ouabain; Phentolamine; Phenylephrine; Rats; Rats, Wistar | 2001 |
Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Arterioles; Blood Pressure; Enalapril; Endothelium, Vascular; Kidney Medulla; Laser-Doppler Flowmetry; Male; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regional Blood Flow; Renal Artery | 2001 |
Effect of nitric oxide inhibition on kidney function in experimental renovascular hypertension.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Constriction; Enzyme Inhibitors; Hypertension, Renovascular; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Reference Values; Renal Circulation | 2001 |
Paradoxically enhanced endothelin-B receptor-mediated vasoconstriction in conscious old monkeys.
Topics: Aging; Angiotensin II; Animals; Consciousness; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Macaca fascicularis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptides, Cyclic; Phenylephrine; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Vasoconstriction; Vasoconstrictor Agents; Viper Venoms | 2001 |
[The effect of inhibition of nitric oxide synthesis on vasoregulatory factors in pregnant rats].
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Endothelin-1; Female; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pre-Eclampsia; Pregnancy; Random Allocation; Rats; Rats, Wistar; Vasodilation | 1999 |
Interaction of angiotensin II and nitric oxide in isolated perfused afferent arterioles of mice.
Topics: Analysis of Variance; Angiotensin II; Animals; Arginine; Arterioles; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney; Mice; Mice, Knockout; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Perfusion; Statistics, Nonparametric; Vasoconstriction; Videotape Recording | 2001 |
Cyclic AMP elevating agents and nitric oxide modulate angiotensin II-induced leukocyte-endothelial cell interactions in vivo.
Topics: Analysis of Variance; Angiotensin II; Animals; Cell Communication; Cells, Cultured; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Leukocytes; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Rats; Rats, Sprague-Dawley | 2001 |
Endothelium-dependent desensitization to angiotensin II in rabbit aorta: the mechanisms involved.
Topics: Angiotensin II; Animals; Antifungal Agents; Aorta, Thoracic; Calcium; Cromakalim; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Indomethacin; Male; Miconazole; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Potassium Channel Blockers; Rabbits; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
Role of nitric oxide in regional blood flow in angiotensin II-induced hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Circulation; Enzyme Inhibitors; Hemodynamics; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitro Compounds; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2001 |
Endothelial nitric oxide synthase protein is reduced in the renal medulla of two-kidney, one-clip hypertensive rats.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Enzyme Inhibitors; Heart Rate; Hypertension, Renovascular; Kidney Cortex; Kidney Medulla; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Regional Blood Flow; Renal Circulation; Tissue Distribution | 2001 |
Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradykinin; Heart Ventricles; In Vitro Techniques; Indomethacin; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Peptide Fragments; Rats; Rats, Wistar | 2001 |
Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Angiotensin II; Animals; Antihypertensive Agents; Arachidonic Acid; Clotrimazole; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Gene Expression Regulation; Imidazoles; In Vitro Techniques; Indomethacin; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Oligopeptides; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renal Insufficiency; RNA, Messenger; Vasodilation | 2001 |
Prostanoids, but not nitric oxide, counterregulate angiotensin II mediated vasoconstriction in vivo.
Topics: Adrenal Glands; Angiotensin II; Animals; Enzyme Inhibitors; Hemodynamics; Indomethacin; Intestines; Kidney; Male; Mesentery; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Pancreas; Prostaglandins; Rats; Rats, Wistar; Regional Blood Flow; Skin; Spleen; Stomach; Vasoconstriction | 2001 |
Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs.
Topics: Angiotensin II; Animals; Dogs; Enzyme Inhibitors; Fatty Acids; Glucose; Hemodynamics; Lactic Acid; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidation-Reduction | 2002 |
Antiproliferative effects of D-polymannuronic sulfate on rat vascular smooth muscle cells and its related mechanisms.
Topics: Angiotensin II; Animals; Aorta; Calcium; Cell Cycle; Cell Division; Cells, Cultured; DNA; Hexuronic Acids; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NG-Nitroarginine Methyl Ester; Rats | 2001 |
Angiotensin II induces phenotype-dependent apoptosis in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Apoptosis; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenotype; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin | 2001 |
Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Apoptosis; Hypertension; Immunohistochemistry; Kidney; Kidney Glomerulus; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Rats; Rats, Inbred SHR; Regional Blood Flow | 2001 |
Vessel-specific stimulation of protein synthesis by nitric oxide synthase inhibition: role of extracellular signal-regulated kinases 1/2.
Topics: Angiotensin II; Animals; Aorta; Autoradiography; Blood Pressure; Cyclic GMP; Enzyme Inhibitors; Mesenteric Arteries; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Renin; Stimulation, Chemical | 2002 |
Cardiac and renal effects of growth hormone in volume overload-induced heart failure: role of NO.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cyclic GMP; Enzyme Inhibitors; Growth Hormone; Heart; Heart Failure; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Organ Size; Rats; Rats, Wistar; Recombinant Proteins; RNA, Messenger; Ventricular Dysfunction, Left | 2002 |
Salt-sensitive hypertension resulting from nitric oxide synthase inhibition is associated with loss of regulation of angiotensin II in the rat.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Enzyme Inhibitors; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Rats; Rats, Inbred WKY; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary | 2002 |
Effect of angiotensin-(1-7) on jejunal absorption of water in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Imidazoles; Indomethacin; Jejunum; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Prostaglandin-Endoperoxide Synthases; Protein Binding; Pyridines; Rats; Rats, Wistar; Time Factors; Water | 2002 |
Effects of nitric oxide and angiotensin II and their interaction on water uptake in Rana catesbeiana.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Body Water; Heart Rate; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Osmolar Concentration; Permeability; Potassium; Rana catesbeiana; Skin; Sodium; Time Factors | 2002 |
Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats.
Topics: Angiotensin II; Animals; Arteries; Arterioles; Blood Pressure; Diabetes Mellitus; Endothelins; Heart Rate; Hypertension; Male; Microcirculation; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Obesity; Phentolamine; Propranolol; Rats; Rats, Zucker; Thinness; Vasoconstriction | 2002 |
Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.
Topics: Aldosterone; Angiotensin II; Animals; Diet, Sodium-Restricted; Disease Models, Animal; Eplerenone; Heart Diseases; Male; Mineralocorticoid Receptor Antagonists; NG-Nitroarginine Methyl Ester; Potassium; Rats; Rats, Wistar; Spironolactone | 2002 |
Long-term inhibition of nitric oxide synthesis increases arterial thrombogenecity in rat carotid artery.
Topics: Administration, Oral; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antithrombins; Arginine; Blood Flow Velocity; Blood Pressure; Carotid Arteries; Carotid Artery Thrombosis; Enzyme Inhibitors; Gene Expression Regulation; Heart Rate; Imidazoles; Imidazolidines; Injections, Intravenous; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Pipecolic Acids; Platelet Aggregation; Prothrombin Time; Rats; Rats, Inbred WKY; Sulfonamides; Thromboplastin; Transcription, Genetic | 2002 |
Hypertension in L-NAME-treated diabetic rats depends on an intact sympathetic nervous system.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glomerular Filtration Rate; Hypertension, Renal; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Sodium; Sympathetic Nervous System | 2002 |
Volume expansion during acute angiotensin II receptor (AT(1)) blockade and NOS inhibition in conscious dogs.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Proteins; Blood Volume; Consciousness; Dogs; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Heart Rate; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Osmolar Concentration; Potassium; Receptor, Angiotensin, Type 1; Sodium; Tetrazoles | 2002 |
PAR-2 elicits afferent arteriolar vasodilation by NO-dependent and NO-independent actions.
Topics: Acetylcholine; Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arterioles; Enzyme Inhibitors; Hydronephrosis; Ibuprofen; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptor, PAR-2; Receptors, Thrombin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasodilation | 2002 |
Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blotting, Western; Common Bile Duct; Enzyme Inhibitors; Hematocrit; Hypertension, Portal; Ligation; Liver Circulation; Liver Cirrhosis; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norepinephrine; Plasma Volume; Rats; Rats, Sprague-Dawley; Renin | 2002 |
Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Arginine; Bradykinin; Bradykinin Receptor Antagonists; Cell Division; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Gene Expression; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Transfection | 2002 |
Cytosolic phospholipase A(2) in hypoxic pulmonary vasoconstriction.
Topics: Angiotensin II; Animals; Calcium; Cell Membrane; Cyclooxygenase Inhibitors; Cytosol; Eicosanoids; Enzyme Inhibitors; Gas Chromatography-Mass Spectrometry; Genotype; Hypoxia; Indomethacin; Lung; Mice; NG-Nitroarginine Methyl Ester; Oxygen; Phospholipases A; Time Factors; Vasoconstriction | 2002 |
Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibodies, Monoclonal; Benzimidazoles; Biphenyl Compounds; Collagen; Cyclooxygenase 2; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Endothelial Growth Factors; Female; Imidazoles; Isoenzymes; Laminin; Lymphokines; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prostaglandin-Endoperoxide Synthases; Proteoglycans; Pyridines; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sulfonamides; Tetrazoles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Effect of exogenous and endogenous angiotensin II on intrarenal distribution of glomerular filtration rate in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aprotinin; Glomerular Filtration Rate; Hemostatics; Juxtaglomerular Apparatus; Kidney; Kidney Cortex; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Circulation; Vascular Resistance | 2002 |
Renoprotective mechanisms of angiotensin II antagonism in experimental chronic renal failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Autoradiography; Blood Pressure; Body Weight; Captopril; Drinking; Enzyme Inhibitors; Female; Glomerulonephritis; Glomerulonephritis, Membranous; Imidazoles; Kidney; Kidney Failure, Chronic; Microscopy, Fluorescence; NG-Nitroarginine Methyl Ester; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Tetrazoles | 2002 |
Effects of losartan on the blood-brain barrier permeability in long-term nitric oxide blockade-induced hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Blood-Brain Barrier; Coloring Agents; Enzyme Inhibitors; Evans Blue; Hypertension; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar | 2002 |
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Coronary Circulation; Coronary Vessels; Dogs; Drug Synergism; Imidazoles; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptors, Angiotensin; Tetrazoles; Thiazepines; Vasodilation | 2002 |
Tempol selectively attenuates angiotensin II evoked vasoconstrictor responses in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Aorta; Cyclic N-Oxides; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Free Radical Scavengers; Luminescent Measurements; Male; Mesenteric Arteries; Models, Cardiovascular; NG-Nitroarginine Methyl Ester; Perfusion; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Spin Labels; Superoxides; Vasoconstriction | 2002 |
Cross-talk between AT(1) and AT(2) angiotensin receptors in rat anococcygeus smooth muscle.
Topics: Angiotensin II; Animals; Imidazoles; Kinetics; Losartan; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Prazosin; Pyridines; Rats; Rats, Wistar; Receptor Cross-Talk; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 2002 |
Angiotensin II stimulates basolateral K channels in rat cortical collecting ducts.
Topics: Angiotensin II; Animals; Cyclic GMP; Enzyme Inhibitors; Kidney Cortex; Kidney Tubules, Collecting; Male; Membrane Potentials; NG-Nitroarginine Methyl Ester; Nitric Oxide; Patch-Clamp Techniques; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Specific Pathogen-Free Organisms; Vasoconstrictor Agents | 2003 |
Role of nitric oxide on the vasorelaxant effect of atrial natriuretic peptide on rabbit aorta basal tone.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Enzyme Inhibitors; Female; In Vitro Techniques; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rabbits; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2002 |
Gender difference in vascular and platelet reactivity to thromboxane A(2)-mimetic U46619 and to endothelial dependent vasodilation in Zucker fatty (hypertensive, hyperinsulinemic) diabetic rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Blood Pressure; Diabetes Mellitus, Type 2; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Female; Kidney Cortex; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Platelet Aggregation; Rats; Rats, Zucker; Renal Circulation; Sex Characteristics; Vasoconstrictor Agents; Vasodilation | 2003 |
Tissue-specific response to interstitial angiotensin II in humans.
Topics: Adipose Tissue; Adult; Angiotensin II; Enzyme Inhibitors; Extracellular Space; Glycolysis; Humans; Lactic Acid; Lipolysis; Male; Microdialysis; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Norepinephrine; Organ Specificity; Perfusion; Pyruvic Acid; Regional Blood Flow | 2003 |
The serpin protease-nexin 1 is present in rat aortic smooth muscle cells and is upregulated in L-NAME hypertensive rats.
Topics: Administration, Oral; Amyloid beta-Protein Precursor; Angiotensin II; Animals; Aorta; Calcium; Carrier Proteins; Cell Division; Cells, Cultured; Humans; Hypertension; Immunohistochemistry; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Protease Nexins; Rats; Rats, Wistar; Receptors, Cell Surface; Recombinant Proteins; Serpin E2; Serpins; Thrombin; Up-Regulation | 2003 |
The novel serine protease PreR-Co promotes endothelium-independent vasorelaxation in rabbit aortic rings.
Topics: Angiotensin II; Animals; Aorta; Bradykinin; Endopeptidases; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Kallikreins; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rabbits; Serine Proteinase Inhibitors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2003 |
Angiotensin II and renal medullary blood flow in Lyon rats.
Topics: Angiotensin II; Animals; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Hypertension; Indomethacin; Kidney Medulla; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Rats; Rats, Inbred Strains; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, Angiotensin; Reference Values; Renal Circulation; Vasoconstrictor Agents | 2003 |
Inhibitory effects of atropine and hexamethonium on the angiotensin II-induced contractions of rat anococcygeus smooth muscles.
Topics: Angiotensin II; Animals; Atropine; Cholinergic Antagonists; Cholinesterase Inhibitors; Depression, Chemical; Dose-Response Relationship, Drug; Hexamethonium; In Vitro Techniques; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Neostigmine; NG-Nitroarginine Methyl Ester; Nicotinic Antagonists; Rats; Rats, Wistar; Vasoconstrictor Agents; Yohimbine | 2003 |
Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amides; Angiotensin II; Animals; Cells, Cultured; Cyclic GMP; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Hypertension; Indoles; Intracellular Signaling Peptides and Proteins; Maleimides; Muscle Proteins; Muscle, Smooth, Vascular; Myosin-Light-Chain Phosphatase; NG-Nitroarginine Methyl Ester; Phosphoprotein Phosphatases; Phosphoproteins; Phosphorylation; Protein Kinase C; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Threonine | 2003 |
Angiotensin II activates a nitric-oxide-driven inhibitory feedback in the rat paraventricular nucleus.
Topics: Angiotensin II; Animals; Enzyme Inhibitors; Feedback, Physiological; Male; Neural Inhibition; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Paraventricular Hypothalamic Nucleus; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2003 |
Prostaglandins but not nitric oxide protect renal medullary perfusion in anaesthetised rats receiving angiotensin II.
Topics: Angiotensin II; Animals; Indomethacin; Infusions, Parenteral; Kidney Medulla; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Perfusion; Prostaglandins; Rats; Rats, Wistar; Regional Blood Flow; Renal Circulation; Vasodilation | 2003 |
Role of endothelium-derived relaxing factors in the renal response to vasoactive agents in hypothyroid rats.
Topics: Angiotensin II; Animals; Biological Factors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hypothyroidism; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phenylephrine; Potassium; Rats; Rats, Wistar; Renal Circulation; Tetraethylammonium Compounds; Thyroxine; Triiodothyronine; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Mislocalization of eNOS and upregulation of cerebral vascular Ca2+ channel activity in angiotensin-hypertension.
Topics: Angiotensin II; Animals; Blotting, Western; Calcium Channels; Calcium Channels, L-Type; Cerebral Arteries; Enzyme Inhibitors; Female; Fluorescein; Hypertension; Membrane Potentials; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Inbred WKY; Up-Regulation | 2003 |
Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; Losartan; Male; Minoxidil; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyridines; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 2003 |
Increased pressor sensitivity to chronic nitric oxide deficiency in hyperthyroid rats.
Topics: Angiotensin II; Animals; Blood Pressure; Creatinine; Enzyme Inhibitors; Heart Rate; Hyperthyroidism; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Potassium; Proteinuria; Rats; Rats, Wistar; Sodium; Thyroxine | 2003 |
Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Biological Availability; Endothelium, Vascular; Hyperhomocysteinemia; Hypertension; In Vitro Techniques; Mesenteric Arteries; Methylenetetrahydrofolate Reductase (NADPH2); Mice; Mice, Knockout; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Superoxides; Vasodilation; Xanthine Oxidase | 2003 |
Regulation of NHE3, NKCC2, and NCC abundance in kidney during aldosterone escape phenomenon: role of NO.
Topics: Aldosterone; Angiotensin II; Animals; Carrier Proteins; Enzyme Inhibitors; Isoenzymes; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptors, Drug; Sodium; Sodium Chloride; Sodium Chloride Symporters; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 3; Symporters | 2003 |
Effect of losartan on renal microvasculature during chronic inhibition of nitric oxide visualized by micro-CT.
Topics: Angiography; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Vessels; Enzyme Inhibitors; Kidney; Losartan; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Circulation; Tomography, X-Ray Computed | 2003 |
Control of arterial pressure by angiotensin II and nitric oxide at the onset of diabetes.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Enalapril; Hypertension; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2003 |
Differential vasoconstrictions induced by angiotensin II: role of AT1 and AT2 receptors in isolated C57BL/6J mouse blood vessels.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Carotid Arteries; Enzyme Inhibitors; Femoral Artery; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Vasoconstriction; Vasoconstrictor Agents | 2003 |
Role of prostaglandin, endothelin and sympathetic nervous system on the L-NAME-induced pressor responses in spontaneously hypertensive rats.
Topics: Acetamides; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chlorisondamine; Cyclooxygenase Inhibitors; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Ganglionic Blockers; Heart Rate; Indomethacin; Injections, Intraventricular; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oligopeptides; Prostaglandins; Rats; Rats, Inbred SHR; Sympathetic Nervous System | 2003 |
Interactions between vasoconstrictors and vasodilators in regulating hemodynamics of distinct vascular beds.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Bosentan; Cyclooxygenase Inhibitors; Dogs; Endothelin Receptor Antagonists; Enzyme Inhibitors; Female; Hemodynamics; Iliac Artery; Kidney; Lung; Male; Meclofenamic Acid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prostaglandins; Receptor, Angiotensin, Type 1; Regional Blood Flow; Sodium; Sulfonamides; Vasoconstriction; Vasodilation | 2003 |
Apoptosis and NFkappaB activation are simultaneously induced in renal tubulointerstitium in experimental hypertension.
Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Enzyme Inhibitors; Hypertension; Kidney; Kidney Tubules; Male; NF-kappa B; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Transcription Factor RelA | 2003 |
Vimentin and heat shock protein expression are induced in the kidney by angiotensin and by nitric oxide inhibition.
Topics: Angiotensin II; Animals; Chaperonin 60; Enzyme Inhibitors; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Immunohistochemistry; Kidney; Kidney Cortex; Kidney Tubules, Proximal; Lymphocytes; Macrophages; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vimentin | 2003 |
NADPH oxidase and enhanced superoxide generation in intrauterine undernourished rats: involvement of the renin-angiotensin system.
Topics: Acetophenones; Angiotensin II; Animals; Cyclooxygenase Inhibitors; Diclofenac; Enzyme Inhibitors; Female; Fetal Growth Retardation; Male; Mesenteric Arteries; Microscopy, Fluorescence; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxypurinol; Pregnancy; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System; Superoxides; Vasodilation; Xanthine Oxidase | 2003 |
Facilitation of renal autoregulation by angiotensin II is mediated through modulation of nitric oxide.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cyclic N-Oxides; Endothelium-Dependent Relaxing Factors; Erythrocytes; Glomerular Filtration Rate; Homeostasis; Indomethacin; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Perfusion; Phenylephrine; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Spin Labels; Vasoconstriction | 2003 |
The receptors and role of angiotensin II in knee joint blood flow regulation and role of nitric oxide in modulation of their function.
Topics: Angiotensin II; Animals; Knee Joint; Losartan; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rabbits; Receptor, Angiotensin, Type 1; Vascular Resistance; Vasoconstriction | 2003 |
Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Coronary Artery Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Myocardium; NG-Nitroarginine Methyl Ester; Plasminogen Activator Inhibitor 1; Proteinuria; Sodium, Dietary; Spironolactone | 2003 |
Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cyclooxygenase Inhibitors; Dogs; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Hemodynamics; Imidazoles; Indomethacin; Kidney Glomerulus; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prostaglandins; Renal Circulation; Tetrazoles; Time Factors | 2004 |
AT1 receptor expression in glomeruli from NO-deficient rats.
Topics: Administration, Oral; Angiotensin II; Animals; Calcium; Captopril; Glomerular Mesangium; Glutamyl Aminopeptidase; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptidyl-Dipeptidase A; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2003 |
NO and endogenous angiotensin II interact in the generation of renal sympathetic nerve activity in conscious rats.
Topics: Angiotensin II; Animals; Blood Pressure; Diet; Enzyme Inhibitors; Heart Rate; Hydralazine; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Sprague-Dawley; Sodium, Dietary; Sympathetic Nervous System; Vasodilator Agents | 2004 |
Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium.
Topics: Angiotensin II; Animals; Arterioles; Capillaries; Chemotaxis, Leukocyte; Collateral Circulation; Cytokines; Enzyme Inhibitors; Granulocytes; Macrophages; Male; Mice; Mice, Knockout; Myocardial Infarction; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 1; Sarcoma 180; T-Lymphocytes; Ventricular Remodeling | 2004 |
Redox modulation of Gi protein expression and adenylyl cyclase signaling: role of nitric oxide.
Topics: Adenylyl Cyclases; Angiotensin II; Animals; Blood Pressure; Cholera Toxin; Colforsin; Enzyme Inhibitors; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gs; Guanosine 5'-O-(3-Thiotriphosphate); Heart; Male; Muscarinic Agonists; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidation-Reduction; Oxotremorine; Rats; Rats, Sprague-Dawley; Signal Transduction; Tissue Extracts | 2004 |
Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Bone Marrow Transplantation; Chemokine CCL2; Chemotaxis, Leukocyte; Enzyme Inhibitors; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Inflammation; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Monocytes; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Olmesartan Medoxomil; Pilot Projects; Radiation Chimera; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, CCR2; Receptors, Chemokine; Recombinant Fusion Proteins; Superoxide Dismutase; Tetrazoles; Up-Regulation | 2004 |
Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo.
Topics: Alleles; Angiotensin II; Animals; Apelin Receptors; Blood Pressure; Blotting, Northern; DNA, Complementary; Endothelium; Endothelium, Vascular; Enzyme Inhibitors; Homozygote; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Models, Genetic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phosphorylation; Protein Structure, Tertiary; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Recombination, Genetic; RNA; Serine; Time Factors | 2004 |
Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Topics: Angiotensin II; Animals; Biomarkers; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrosis; Infusions, Intravenous; Kidney; Models, Cardiovascular; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Proteinuria; Rats; Rats, Sprague-Dawley; Renin; Time Factors; Troponin T; Vasoconstrictor Agents | 2004 |
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries.
Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Biphenyl Compounds; Child; Child, Preschool; Coronary Circulation; Coronary Vessels; Cyclic GMP; Female; Humans; Imidazoles; Irbesartan; Male; Microcirculation; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; RNA, Messenger; Tetrazoles; Vasodilation | 2004 |
Free radical activity depends on underlying vasoconstrictors in renal microcirculation.
Topics: Angiotensin II; Animals; Arterioles; Cyclic N-Oxides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Free Radicals; Kidney; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Norepinephrine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Spin Labels; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2004 |
Influence of selective nitric oxide synthetase inhibitor for treatment of refractory haemorrhagic shock.
Topics: Analysis of Variance; Angiotensin II; Animals; Biomarkers; Blood Pressure Determination; Creatinine; Guanidines; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Shock, Hemorrhagic; Survival Rate | 2004 |
Angiotensin II-induced relaxation of anococcygeus smooth muscle via desensitization of AT1 receptor, and activation of AT2 receptor associated with nitric-oxide synthase pathway.
Topics: Adenine; Angiotensin II; Animals; Blotting, Western; CD13 Antigens; Drug Interactions; Glutamyl Aminopeptidase; Imidazoles; Losartan; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Peptides; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrodotoxin; Thiorphan | 2004 |
The renin-angiotensin system: a 21st century perspective.
Topics: Angiotensin II; Animals; Diabetes Mellitus; Disease Models, Animal; Humans; NG-Nitroarginine Methyl Ester; Reactive Oxygen Species; Renin; Renin-Angiotensin System | 2004 |
Nitric oxide counteracts angiotensin II induced contraction in efferent arterioles in mice.
Topics: Angiotensin II; Animals; Arterioles; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Vasoconstriction | 2004 |
Comparative study of the inhibitory effects of adrenomedullin on angiotensin II contraction in rat conductance and resistance arteries.
Topics: Adrenomedullin; Angiotensin II; Animals; Aorta, Thoracic; Drug Interactions; Enzyme Inhibitors; In Vitro Techniques; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Peptides; Phenylephrine; Potassium; Rats; Rats, Wistar; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2004 |
NO and angiotensin II effects on blood pressure and fluid homeostasis.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Proteins; Drinking Behavior; Hematocrit; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Water-Electrolyte Balance | 1997 |
Redundant signaling mechanisms contribute to the vasodilatory response of the afferent arteriole to proteinase-activated receptor-2.
Topics: Angiotensin II; Animals; Apamin; Arterioles; Charybdotoxin; Fatty Acids, Unsaturated; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oligopeptides; Ouabain; Rats; Rats, Sprague-Dawley; Receptor, PAR-2; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Tetraethylammonium; Trypsin; Vasodilation | 2005 |
Chronic ANG II infusion increases NO generation by rat descending vasa recta.
Topics: Acetylcholine; Angiotensin II; Animals; Arterioles; Biological Availability; Calcium Signaling; Cyclic N-Oxides; Drug Administration Schedule; Enzyme Inhibitors; Ethidium; Infusion Pumps; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Renal Circulation; Spin Labels; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
Modulation of hypoxic pulmonary vasoconstriction is time and nitric oxide dependent in a peritonitis model of sepsis.
Topics: Angiotensin II; Animals; Blood Pressure; Blotting, Western; Enzyme Inhibitors; Hypoxia; In Vitro Techniques; Lung; Lysine; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peritonitis; Prospective Studies; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Sepsis; Time Factors; Vasoconstriction | 2004 |
Mechanisms of impaired vascular response to ANG II in perivascular injured carotid arteries of ovariectomized rat.
Topics: Angiotensin II; Animals; Calcium; Carotid Artery Injuries; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Imidazoles; Implants, Experimental; Indomethacin; Muscle, Smooth, Vascular; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Ovariectomy; Photomicrography; Pyridines; Rabbits; Rats; Rats, Wistar; Silicones; Time Factors; Vasoconstriction | 2004 |
Tempol augments angiotensin II-induced AT2 receptor-mediated relaxation in diabetic rat thoracic aorta.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antioxidants; Aorta, Thoracic; Blood Pressure; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Drug Synergism; Enzyme Inhibitors; Hyperglycemia; Male; NG-Nitroarginine Methyl Ester; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Spin Labels; Superoxide Dismutase; Tritium; Vasoconstrictor Agents; Vasodilation | 2004 |
Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Arginine Vasopressin; Enzyme Inhibitors; Glomerular Filtration Rate; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Renal Circulation; Shock, Septic; Urine; Vasoconstrictor Agents | 2005 |
Effects of lipopolysaccharide on the blood-brain barrier permeability in prolonged nitric oxide blockade-induced hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Astrocytes; Blood-Brain Barrier; Capillary Permeability; Cerebellum; Coloring Agents; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Hypertension; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Membrane Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphoproteins; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Zonula Occludens-1 Protein | 2005 |
Interaction of central Ang II and NO on the cardiac sympathetic afferent reflex in dogs.
Topics: Afferent Pathways; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Citrulline; Dogs; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Administration Routes; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Female; Heart; Heart Rate; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Reflex; Sympathectomy; Sympathetic Nervous System; Thiourea; Time Factors; Vagotomy | 2005 |
Angiotensin II as the link between nitric oxide and neuroadrenergic function.
Topics: Angiotensin II; Humans; NG-Nitroarginine Methyl Ester; Nitric Oxide; Sympathetic Nervous System | 2005 |
Role of nitric oxide in modulating systemic pressor responses to different vasoconstrictors in man.
Topics: Adult; Angiotensin II; Blood Pressure; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Phenylephrine; Receptor, Angiotensin, Type 1; Vasoconstrictor Agents | 2005 |
Effects of atorvastatin on blood-brain barrier permeability during L-NAME hypertension followed by angiotensin-II in rats.
Topics: Angiotensin II; Animals; Atorvastatin; Blood-Brain Barrier; Heptanoic Acids; Hypertension; Male; NG-Nitroarginine Methyl Ester; Permeability; Pyrroles; Rats; Rats, Wistar | 2005 |
Angiotensin II and nitric oxide in neural control of intrarenal blood flow.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Kidney Cortex; Laser-Doppler Flowmetry; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Receptor, Angiotensin, Type 1; Renal Circulation; Sympathetic Nervous System; Tetrazoles | 2005 |
Renal cortical and medullary blood flow responses to L-NAME and ANG II in wild-type, nNOS null mutant, and eNOS null mutant mice.
Topics: Angiotensin II; Animals; Blood Flow Velocity; Kidney Cortex; Kidney Medulla; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Transgenic; Mutation; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Renal Circulation | 2005 |
Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes.
Topics: Amidines; Angiotensin II; Animals; Benzylamines; Blood Pressure; Blotting, Western; Diabetes Mellitus, Experimental; Endothelium, Vascular; Enzyme Inhibitors; Heart Rate; Hemodynamics; Immunohistochemistry; Male; Methoxamine; Neurotensin; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Vascular Diseases; Vasoconstrictor Agents | 2005 |
Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats.
Topics: Angiotensin II; Animals; Baroreflex; Blood Pressure; Blood Pressure Determination; Desoxycorticosterone; Disease Models, Animal; Endothelin-1; Hypertension; Hypertension, Renovascular; Interleukin-1; Kidney Glomerulus; Male; Myocardium; NG-Nitroarginine Methyl Ester; Organ Size; Rats; Rats, Sprague-Dawley; Time Factors; Tumor Necrosis Factor-alpha | 2005 |
NO-independent mechanism mediates tempol-induced renal vasodilation in SHR.
Topics: Angiotensin II; Animals; Cyclic N-Oxides; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred SHR; Renal Circulation; Spin Labels; Vascular Resistance; Vasodilation | 2005 |
Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide.
Topics: Angiotensin II; Animals; Enzyme Inhibitors; Male; Mesenteric Veins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Culture Techniques; Portal Vein; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasoconstriction; Vasoconstrictor Agents | 2005 |
Short-term angiotensin(1-7) receptor MAS stimulation improves endothelial function in normotensive rats.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Hypotension; Imidazoles; Injections, Intravenous; Male; NG-Nitroarginine Methyl Ester; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reference Values; Vasodilator Agents | 2005 |
Angiotensin II modulates renal sympathetic neurotransmission through nitric oxide in AT2 receptor knockout mice.
Topics: Angiotensin II; Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epinephrine; Kidney; Male; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Perfusion; Polymerase Chain Reaction; Receptor, Angiotensin, Type 2; Sympathetic Nervous System; Up-Regulation; Vascular Resistance | 2005 |
In vivo characterization of the angiotensin-(1-7)-induced dopamine and gamma-aminobutyric acid release in the striatum of the rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chromatography; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; gamma-Aminobutyric Acid; Imidazoles; Male; Microdialysis; NG-Nitroarginine Methyl Ester; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Sulfonic Acids; Tetrazoles; Time Factors | 2005 |
The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of mas-knockout mice.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta, Thoracic; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oligopeptides; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
Nitric oxide modulates angiotensin II-induced endothelial vasoconstrictor prostanoid release.
Topics: Angiotensin II; Animals; Antioxidants; Aorta, Thoracic; Ascorbic Acid; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Potassium Channel Blockers; Prostaglandins; Rabbits; Receptors, Thromboxane; Tetraethylammonium; Vasoconstriction; Vasomotor System | 2005 |
Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Drug Synergism; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Indomethacin; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; NG-Nitroarginine Methyl Ester; Peptide Fragments; Perfusion; Pressure; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Vasoconstrictor Agents | 2005 |
Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice.
Topics: Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Endothelin-1; Enzyme Inhibitors; Gene Expression; In Vitro Techniques; Kidney Glomerulus; Male; Mice; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Polymerase Chain Reaction; Receptors, Angiotensin; Renal Artery; Renin; RNA, Messenger; Vasoconstriction; Vasoconstrictor Agents | 2005 |
Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species.
Topics: Angiotensin II; Animals; Cell Culture Techniques; Enzyme Inhibitors; Kidney Tubules, Proximal; Mice; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Oxidative Stress; Phosphorylation; Protein Biosynthesis; Reactive Oxygen Species; RNA, Messenger; Vascular Endothelial Growth Factor A | 2006 |
Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Protein Serine-Threonine Kinases; Quaternary Ammonium Compounds; rho-Associated Kinases; Vascular Diseases | 2005 |
Synergistic effect of angiotensin II and nitric oxide synthase inhibitor in increasing aortic stiffness in mice.
Topics: Angiotensin II; Animals; Aorta; Drug Combinations; Drug Synergism; Elasticity; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Stress, Mechanical; Vascular Resistance | 2006 |
L-NAME hypertension: trying to fit the pieces together.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiovascular System; Enzyme Inhibitors; Hypertension; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Prostaglandins; Rats; Renin-Angiotensin System; Superoxides; Sympathetic Nervous System | 2006 |
Analysis of the mechanisms underlying the vasorelaxant action of angiotensin II in the isolated rat carotid.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Carotid Arteries; Dose-Response Relationship, Drug; Drug Antagonism; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Oxadiazoles; Peptide Fragments; Phenylephrine; Quinoxalines; Rats; Rats, Wistar; Saralasin; Vasoconstrictor Agents; Vasodilation | 2006 |
Are multiple angiotensin receptor types involved in angiotensin (1-7) actions on isolated rat portal vein.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Portal Vein; Rats; Receptors, Angiotensin | 2005 |
Angiotensin II effect on hydraulic permeability: interaction with endothelin-1, nitric oxide, and platelet activating factor.
Topics: Angiotensin II; Animals; Capillary Permeability; Drug Interactions; Endothelin A Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Female; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 2006 |
Renal endothelial dysfunction and impaired autoregulation after ischemia-reperfusion injury result from excess nitric oxide.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Endothelium; Homeostasis; In Vitro Techniques; Indomethacin; Kidney; Methacholine Chloride; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Phenylephrine; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vasoconstriction | 2006 |
Role of superoxide and angiotensin II suppression in salt-induced changes in endothelial Ca2+ signaling and NO production in rat aorta.
Topics: Angiotensin II; Animals; Antioxidants; Aorta, Thoracic; Blood Pressure; Calcium; Calcium Signaling; Cyclic N-Oxides; Endothelium, Vascular; Enzyme Inhibitors; Histamine; In Vitro Techniques; Male; Methacholine Chloride; Muscarinic Agonists; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Spin Labels; Superoxides; Thapsigargin | 2006 |
L-type calcium channels mediate water intake induced by angiotensin injection into median preoptic nucleus.
Topics: Angiotensin II; Animals; Calcium; Calcium Channels, L-Type; Drinking; Indazoles; Male; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Preoptic Area; Rats | 2006 |
B(2)-receptor modulation of the reactivity to phenylephrine and angiotensin II in the carotid artery of normotensive rats after trandolapril treatment.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Carotid Arteries; Endothelium; In Vitro Techniques; Indoles; Indomethacin; Male; Muscle Contraction; NG-Nitroarginine Methyl Ester; Peptidyl-Dipeptidase A; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2 | 2006 |
Selective inhibition of p38alpha MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury.
Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Body Weight; Cardiac Output; Caspase 3; Caspases; Enzyme Inhibitors; Heart; Indoles; Inflammation; Male; Mitogen-Activated Protein Kinase 14; Myocardial Infarction; Myocardium; NG-Nitroarginine Methyl Ester; Organ Size; Rats; Rats, Wistar; Reperfusion Injury; Stroke Volume; Vasoconstrictor Agents | 2006 |
Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat.
Topics: Angiotensin II; Animals; Arachidonic Acid; Blood Pressure; Blotting, Western; Body Weight; Cyclooxygenase 1; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Enzyme Inhibitors; In Vitro Techniques; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Perfusion; Pressure; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Wistar; Tyrosine | 2006 |
Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion.
Topics: Adipose Tissue; Angiotensin II; Animals; Butadienes; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Immunohistochemistry; In Vitro Techniques; Male; Mesenteric Arteries; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; NADH, NADPH Oxidoreductases; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitriles; Phenylephrine; Protein-Tyrosine Kinases; Rats; Rats, Inbred SHR; Reverse Transcriptase Polymerase Chain Reaction; Superoxide Dismutase; Superoxides; Tyrphostins; Vasoconstriction | 2006 |
Estradiol increases proteinuria and angiotensin II type 1 receptor in kidneys of rats receiving L-NAME and angiotensin II.
Topics: Angiotensin II; Animals; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression Regulation; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide; Ovariectomy; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasoconstrictor Agents | 2006 |
The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Coronary Vessels; Disease Models, Animal; Enzyme Inhibitors; Heart Rate; Heart Ventricles; Imidazoles; Ligation; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Time Factors; Vasoconstriction; Vasodilator Agents; Ventricular Function, Left | 2007 |
Effects of inhibition of the Na+/K+/2Cl- cotransporter on myogenic and angiotensin II responses of the rat afferent arteriole.
Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Bumetanide; Dose-Response Relationship, Drug; Furosemide; Gene Expression; In Vitro Techniques; Kidney Glomerulus; Male; Myocytes, Smooth Muscle; NG-Nitroarginine Methyl Ester; Perfusion; Rats; Rats, Sprague-Dawley; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2007 |
Hydrogen peroxide modulates angiotensin II-induced contraction of mesenteric arteries from streptozotocin-induced diabetic rats.
Topics: Angiotensin II; Animals; Catalase; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Hydrogen Peroxide; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Inbred WKY; Streptozocin; Superoxide Dismutase; Vascular Resistance | 2007 |
Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta, Thoracic; In Vitro Techniques; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Vasodilation | 2007 |
Enhanced AT1 receptor-mediated vasocontractile response to ANG II in endothelium-denuded aorta of obese Zucker rats.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Body Weight; Endothelial Cells; Endothelin-1; Enzyme Inhibitors; In Vitro Techniques; Losartan; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitroprusside; Obesity; Potassium Chloride; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2007 |
Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Blotting, Western; Cholesterol; Dietary Fats; Endothelin-1; Endothelium, Vascular; Gene Expression; Glucose Tolerance Test; Hydroxyl Radical; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Obesity; Receptors, Angiotensin; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; Vasoconstrictor Agents; Vasodilator Agents | 2007 |
Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II.
Topics: Angiotensin II; Animals; Aorta; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biopterins; Blood Pressure; Endothelium, Vascular; Enzyme Inhibitors; Glutathione Disulfide; Hypertension; Isoenzymes; Male; Mice; Mice, Inbred Strains; Mice, Knockout; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Superoxides; Vasodilation | 2007 |
C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice.
Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; C-Reactive Protein; Down-Regulation; Hypertension; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Systole; Telmisartan | 2007 |
Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice.
Topics: Acetylcholine; Adipokines; Angiotensin II; Animals; Aorta; Apelin; Apelin Receptors; Blotting, Western; Carrier Proteins; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Mice; Mice, Inbred Strains; Models, Animal; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasodilation; Vasodilator Agents | 2007 |
Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
Topics: Aging; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Cardiovascular System; Critical Period, Psychological; Drug Administration Schedule; Enzyme Inhibitors; Hypertension; Kidney; Male; Mortality; NG-Nitroarginine Methyl Ester; Oxidative Stress; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Tetrazoles; Vasoconstrictor Agents | 2007 |
Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiovascular Agents; Cell Proliferation; Cell Size; Cells, Cultured; Cyclic GMP; Fibroblasts; Intracellular Space; L-Lactate Dehydrogenase; Male; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2007 |
Effect of high-salt diet on vascular relaxation and oxidative stress in mesenteric resistance arteries.
Topics: Acetophenones; Angiotensin II; Animals; Cyclic N-Oxides; Diet, Sodium-Restricted; Fluorescein; Fluorescent Dyes; Male; Mesenteric Arteries; Methacholine Chloride; Microscopy, Fluorescence; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Oxypurinol; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Spin Labels; Superoxides; Vascular Resistance; Vasoconstriction; Vasodilation; Xanthine; Xanthine Oxidase | 2007 |
Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Consciousness; Enzyme Inhibitors; Injections, Intraventricular; Male; Molsidomine; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Osmolar Concentration; Oxytocin; Peptide Hormones; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; Sodium; Urine; Vasoconstrictor Agents; Vasopressins | 2007 |
On the mechanism of coronary vasodilation induced by angiotensin-(1-7) in the isolated guinea pig heart.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Bradykinin; Coronary Vessels; Dose-Response Relationship, Drug; Female; Guinea Pigs; Imidazoles; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Pyridines; Vasodilation | 2007 |
Angiotensin-(1-7) blocks the angiotensin II-stimulated superoxide production.
Topics: Acetophenones; Allopurinol; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Drug Antagonism; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Indomethacin; Losartan; Male; NADH, NADPH Oxidoreductases; NG-Nitroarginine Methyl Ester; Onium Compounds; Peptide Fragments; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Superoxides | 2007 |
Targeted and persistent effects of NO mediated by S-nitrosation of tissue thiols in arteries with endothelial dysfunction.
Topics: Angiotensin II; Animals; Anions; Cysteine; Endothelium, Vascular; Male; Models, Biological; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrogen; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Sulfhydryl Compounds | 2007 |
Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage.
Topics: Albuminuria; Angiotensin II; Animals; Atherosclerosis; Cells, Cultured; Endothelial Cells; Gene Expression Regulation; Humans; Hypertension; I-kappa B Proteins; Inflammation; Intercellular Adhesion Molecule-1; Kidney Diseases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Cardiovascular; Nephritis; NF-kappa B; NF-KappaB Inhibitor alpha; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Organ Specificity; Receptor, TIE-1; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sodium Chloride, Dietary; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2007 |
[Effects of Tongxinluo on cell viability and tissue factor in AngII induced vascular endothelial cells].
Topics: Angiotensin II; Cell Line; Cell Survival; Cells, Cultured; Drugs, Chinese Herbal; Endothelium, Vascular; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type I; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboplastin | 2007 |
Involvement of endogenous nitric oxide in angiotensin II-induced activation of vascular mitogen-activated protein kinases.
Topics: Angiotensin II; Animals; Antioxidants; Aorta; Blood Pressure; Cells, Cultured; Cyclic N-Oxides; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Heart Rate; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Spin Labels; Superoxides | 2007 |
Evidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile function.
Topics: Angiotensin I; Angiotensin II; Animals; Desoxycorticosterone; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Erectile Dysfunction; Hypertension; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Penile Erection; Penis; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Sodium Chloride, Dietary; Vasodilator Agents | 2007 |
Different responses to angiotensin-(1-7) in young, aged and diabetic rabbit corpus cavernosum.
Topics: Aging; Angiotensin I; Angiotensin II; Animals; Carbachol; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erectile Dysfunction; Large-Conductance Calcium-Activated Potassium Channels; Male; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Penis; Peptide Fragments; Peptides; Potassium Channel Blockers; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents | 2007 |
Internal mammary artery grafts reactivity in hypertensive patients: role of stretching in extraendothelial nitric oxide.
Topics: Aged; Angiotensin II; Biomechanical Phenomena; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Hypertension; In Vitro Techniques; Male; Mammary Arteries; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Norepinephrine; Potassium Chloride; Stress, Mechanical; Vasodilation | 2007 |
Evidence for Mas-mediated bradykinin potentiation by the angiotensin-(1-7) nonpeptide mimic AVE 0991 in normotensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Hypotension; Imidazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Vasodilator Agents | 2007 |
Lead exposure effect on angiotensin II renal vasoconstriction.
Topics: Administration, Oral; Angiotensin II; Animals; Blotting, Western; Dose-Response Relationship, Drug; Endothelial Cells; Immunohistochemistry; In Vitro Techniques; Injections; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Organometallic Compounds; Papaverine; Perfusion; Rats; Rats, Wistar; Renal Artery; Superoxides; Tyrosine; Vasoconstriction | 2007 |
Angiotensin II response in afferent arterioles of mice lacking either the endothelial or neuronal isoform of nitric oxide synthase.
Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Enzyme Inhibitors; Female; Juxtaglomerular Apparatus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; RNA, Messenger; Vasoconstrictor Agents | 2008 |
Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release.
Topics: Angiotensin II; Animals; Blood Pressure; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Indazoles; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norepinephrine; Renal Circulation; Vascular Resistance; Vasoconstrictor Agents | 2008 |
Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Enalaprilat; Enzyme Inhibitors; Glomerular Filtration Rate; Hypertension, Renovascular; Imidazoles; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxygen; Partial Pressure; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; Surgical Instruments; Tetrazoles; Vascular Resistance | 2008 |
[Inhibitory effects of emodin on proliferation of rat vascular smooth muscle cell induced by angiotensin II].
Topics: Angiotensin II; Animals; Arginine; Cell Line; Cell Proliferation; Emodin; Immunohistochemistry; Male; Myocytes, Smooth Muscle; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Proliferating Cell Nuclear Antigen; Rats; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Estrogen, nitric oxide, and hypertension differentially modulate agonist-induced contractile responses in female transgenic (mRen2)27 hypertensive rats.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Aorta; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Estradiol; Female; Hypertension; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Ovariectomy; Phenylephrine; Rats; Rats, Sprague-Dawley; Renin; Serotonin; Vasoconstriction; Vasoconstrictor Agents | 2008 |
Nitric oxide deficiency and increased adenosine response of afferent arterioles in hydronephrotic mice with hypertension.
Topics: Adenosine; Angiotensin II; Animals; Arterioles; Disease Models, Animal; Enzyme Inhibitors; Hydronephrosis; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Superoxide Dismutase; Superoxide Dismutase-1; Transforming Growth Factors; Vasoconstriction; Vasoconstrictor Agents | 2008 |
Angiotensin II enhances EGF receptor expression levels via ROS formation in HaCaT cells.
Topics: Angiotensin II; Base Sequence; Cell Line; Cell Proliferation; DNA Primers; ErbB Receptors; Gene Expression; Humans; Keratinocytes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Reactive Oxygen Species; RNA, Messenger; Xanthine; Xanthine Oxidase | 2008 |
Alpha2-antiplasmin is a critical regulator of angiotensin II-mediated vascular remodeling.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cell Proliferation; Collagen Type I; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Eye Proteins; Fibrosis; Gelatinases; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nerve Growth Factors; NG-Nitroarginine Methyl Ester; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Serpins; Thoracic Arteries; Tumor Suppressor Protein p53 | 2008 |
Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT2 receptor?
Topics: Angiotensin II; Angiotensin III; Animals; Coronary Vessels; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Ligands; Male; NG-Nitroarginine Methyl Ester; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Vasoconstriction | 2008 |
Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Bradykinin; Heart; Imidazoles; In Vitro Techniques; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Oligopeptides; Phenylalanine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sympathetic Nervous System; Tranexamic Acid; Vasoconstrictor Agents | 2008 |
Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Anesthesia; Angiotensin II; Animals; Blood Gas Analysis; Blood Pressure; Cardiac Output; Heart Rate; Hypoxia; Injections, Intravenous; Isradipine; Lung; Male; NG-Nitroarginine Methyl Ester; Protein Kinase Inhibitors; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Vascular Resistance; Vasodilator Agents | 2008 |
Calcitonin gene-related peptide inhibits angiotensin II-mediated vasoconstriction in human radial arteries: role of the Kir channel.
Topics: 4-Aminopyridine; Aged; Angiotensin II; Apamin; Barium; Calcitonin Gene-Related Peptide; Charybdotoxin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; In Vitro Techniques; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Potassium Channel Blockers; Potassium Channels; Radial Artery; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats.
Topics: Angiotensin II; Animals; Estradiol; Estrogen Replacement Therapy; Female; Gene Expression; Heart; Humans; Models, Animal; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Ovariectomy; Plasminogen Activator Inhibitor 1; Protein Kinase C-delta; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Estrogen; Signal Transduction; Up-Regulation | 2009 |
Angiotensin II-mediated vasodilation is reduced in adult spontaneously hypertensive rats despite enhanced expression of AT2 receptors.
Topics: Acetylcholine; Aging; Angiotensin II; Animals; Blotting, Western; Bradykinin; Gene Expression Regulation; Imidazoles; Losartan; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Pyridines; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 2; Vasodilation | 2009 |
Role of NOX2 in the regulation of afferent arteriole responsiveness.
Topics: Acetophenones; Adenosine; Angiotensin II; Animals; Arterioles; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hypertension; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney Cortex; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renal Circulation; Superoxides; Vasoconstriction; Vasoconstrictor Agents | 2009 |
Experimental induction of salt-sensitive hypertension is associated with lymphocyte proliferative response to HSP70.
Topics: Angiotensin II; Animals; Autoimmunity; Cell Proliferation; Cells, Cultured; Disease Models, Animal; HSP70 Heat-Shock Proteins; Hypertension; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Proteinuria; Rats; Rats, Sprague-Dawley; Salt Tolerance; T-Lymphocytes | 2008 |
Angiotensin II decreases nitric oxide synthase 3 expression via nitric oxide and superoxide in the thick ascending limb.
Topics: Angiotensin II; Animals; Antioxidants; Cells, Cultured; Cyclic N-Oxides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Loop of Henle; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Sodium Chloride; Spin Labels; Superoxides | 2009 |
Reactivity of isolated toad aortic rings to angiotension II: the role of nitric oxide.
Topics: Analysis of Variance; Angiotensin II; Animals; Anura; Aorta; Blood Pressure; Isometric Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Norepinephrine | 2009 |
Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrasentan; Blood Pressure; Endothelin-1; Hydralazine; Hypertension, Malignant; Losartan; Male; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Insufficiency | 2009 |
Cross talk between kinin and angiotensin II receptors in mouse abdominal aorta.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Bradykinin; Imidazoles; Kinins; Mice; Mice, Inbred BALB C; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Polymerase Chain Reaction; Pyridines; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Angiotensin; Vasodilator Agents | 2009 |
Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide.
Topics: Angiotensin II; Animals; Blood Pressure; Blotting, Western; Disease Models, Animal; Enzyme Inhibitors; Estrogens; Female; Ganglionic Blockers; Hexamethonium; Hypertension; Immunohistochemistry; Infusion Pumps, Implantable; Infusions, Subcutaneous; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Orchiectomy; Ornithine; Ovariectomy; Paraventricular Hypothalamic Nucleus; Receptors, Estrogen; Sex Factors; Subfornical Organ; Sympathetic Nervous System; Telemetry; Time Factors; Up-Regulation | 2009 |
Angiotensin II enhances GABA(B) receptor-mediated responses and expression in nucleus tractus solitarii of rats.
Topics: Angiotensin II; Animals; Baclofen; Baroreflex; Bicuculline; Blood Pressure; Disease Models, Animal; GABA Agonists; GABA Antagonists; Hypertension; Infusion Pumps, Implantable; Male; Microinjections; Muscimol; NG-Nitroarginine Methyl Ester; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, GABA-B; Solitary Nucleus; Time Factors; Up-Regulation | 2009 |
Regular exercise produced cardioprotective effects on rat's heart with hypertension induced by L-NAME administration.
Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Body Weight; Disease Models, Animal; Heart; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Physical Conditioning, Animal; Rats | 2009 |
Clopidogrel, independent of the vascular P2Y12 receptor, improves arterial function in small mesenteric arteries from AngII-hypertensive rats.
Topics: Acetylcholine; Adenosine Diphosphate; Angiotensin II; Animals; Blotting, Western; Clopidogrel; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Purinergic P2Y Receptor Antagonists; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thionucleotides; Ticlopidine; Vasodilation; Vasodilator Agents | 2010 |
Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice.
Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; Blood Pressure; Enzyme Inhibitors; Glycosylation; Hypertension; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidase 2; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Reactive Oxygen Species; Superoxides; Time Factors; Vascular Cell Adhesion Molecule-1; Vasculitis | 2010 |
Blood pressure and renal blow flow responses in heme oxygenase-2 knockout mice.
Topics: Administration, Oral; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Female; Heme Oxygenase (Decyclizing); Hypertension; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Renal Circulation; Vascular Resistance; Vasoconstriction | 2009 |
Influence of hypercholesterolemia and hypertension on the integrity of the blood-brain barrier in rats.
Topics: Analysis of Variance; Angiotensin II; Animals; Blood-Brain Barrier; Body Weight; Catalase; Cholesterol; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glutathione; Hypercholesterolemia; Hypertension; Lipoproteins, LDL; Male; Malondialdehyde; Membrane Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphoproteins; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Zonula Occludens-1 Protein | 2009 |
Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Blotting, Western; Butadienes; Cyclic N-Oxides; Extracellular Signal-Regulated MAP Kinases; Hydralazine; Male; Mesenteric Arteries; Mice; Mice, Knockout; Microscopy, Confocal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitriles; Perindopril; Rats; Rats, Wistar; Reactive Oxygen Species; Spin Labels; Tetrazoles; Vascular Resistance; Vasodilator Agents | 2010 |
Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Hyperplasia; Hypertension; Inhibitor of Differentiation Proteins; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Norepinephrine; Organ Specificity; Receptor, Angiotensin, Type 1; Renin; Tunica Media | 2010 |
Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II.
Topics: Aldosterone; Amino Acid Sequence; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Caveolin 1; Endothelial Cells; Male; Mice; Mice, Knockout; Molecular Sequence Data; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Signal Transduction | 2010 |
An angiotensin II- and NF-kappaB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Binding Sites; Blood Pressure; Carotid Arteries; Cell Line; Connexin 43; Connexins; Disease Models, Animal; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Gap Junction alpha-5 Protein; Genes, Reporter; Hypertension, Renovascular; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Smooth Muscle; Nephrectomy; NF-kappa B; NG-Nitroarginine Methyl Ester; Phosphorylation; Promoter Regions, Genetic; Rats; Renin; Time Factors; Transfection; Up-Regulation | 2010 |
Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins.
Topics: Acetylcholine; Angiotensin II; Animals; Calcium Signaling; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Fulvestrant; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitriles; Phenols; Phenylephrine; Potassium Chloride; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Receptors, Estrogen; Receptors, G-Protein-Coupled; Sex Factors; Varicose Veins; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Vena Cava, Inferior | 2010 |
Effects induced by inhibitors of the phosphatidylinositol 3-kinase/Akt and nitric oxide synthase/guanylyl cyclase pathways on the isometric contraction in rat aorta: a comparative study.
Topics: Androstadienes; Angiotensin II; Animals; Aorta, Thoracic; Chromones; Endothelium, Vascular; Guanylate Cyclase; Isometric Contraction; Male; Morpholines; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Oxadiazoles; Phenylephrine; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Potassium; Proto-Oncogene Proteins c-akt; Quinoxalines; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Wortmannin | 2011 |
Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
Topics: Acetylcholine; Administration, Oral; Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Hypotension; In Vitro Techniques; Injections, Intravenous; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phenylephrine; Rats; Rats, Wistar; Vasoconstriction; Vasodilation | 2011 |
Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling.
Topics: Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Endothelium, Vascular; Hydrogen Peroxide; Hypertension; Mice; Mice, Transgenic; Muscle, Smooth, Vascular; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Polymerase Chain Reaction; Up-Regulation; Vasodilation | 2010 |
Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Cell Nucleus; Enzyme Inhibitors; Female; Fluorescent Antibody Technique; Immunohistochemistry; Kidney; Kidney Cortex; Kidney Tubules, Proximal; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Hydrolases; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Radioligand Assay; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Sheep | 2010 |
Collagen XV is necessary for modeling of the extracellular matrix and its deficiency predisposes to cardiomyopathy.
Topics: Age Factors; Aging; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomyopathies; Collagen; Coronary Circulation; Disease Models, Animal; Echocardiography; Elasticity; Enzyme Inhibitors; Extracellular Matrix; Female; Gene Expression Profiling; Gene Expression Regulation; Genotype; Heart Ventricles; Hemodynamics; Hypertension; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Microscopy, Electron; Microscopy, Video; Myocardium; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenotype; Polymerase Chain Reaction; RNA, Messenger; Telemetry; Ventricular Remodeling | 2010 |
Impaired relaxation of cerebral arteries in the absence of elevated salt intake in normotensive congenic rats carrying the Dahl salt-sensitive renin gene.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Congenic; Antioxidants; Blood Pressure; Captopril; Crosses, Genetic; Cyclic N-Oxides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Infusions, Intravenous; Losartan; Male; Middle Cerebral Artery; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred BN; Rats, Inbred Dahl; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary; Spin Labels; Superoxides; Vasodilation; Vasodilator Agents | 2010 |
Involvement of the AT1 receptor in the venoconstriction induced by angiotensin II in both the inferior vena cava and femoral vein.
Topics: Angiotensin II; Animals; Femoral Vein; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Pyridines; Rats; Receptor, Angiotensin, Type 1; Vasoconstriction; Vena Cava, Inferior | 2011 |
Central nitrergic system regulation of neuroendocrine secretion, fluid intake and blood pressure induced by angiotensin-II.
Topics: Angiotensin II; Animals; Arginine; Atrial Natriuretic Factor; Blood Pressure; Brain; Drinking; Injections, Intraventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxytocin; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sodium; Urine; Vasopressins | 2010 |
Hemodynamic responses to aortic depressor nerve stimulation in conscious L-NAME-induced hypertensive rats.
Topics: Angiotensin II; Animals; Aorta; Atenolol; Atropine Derivatives; Baroreflex; Blood Pressure; Electric Stimulation; Heart Rate; Hemodynamics; Hypertension; Male; NG-Nitroarginine Methyl Ester; Parasympatholytics; Prazosin; Rats; Rats, Wistar | 2011 |
Nitric oxide modulates reactivity to angiotensin II in internal mammary arterial grafts in hypertensive patients without associated risk factors.
Topics: Aged; Angiotensin II; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; Hypertension; Male; Mammary Arteries; Membrane Potentials; Middle Aged; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Nitrites; Oxidative Stress; Vasoconstriction | 2011 |
Renal injury in angiotensin II+L-NAME-induced hypertensive rats is independent of elevated blood pressure.
Topics: Acute Kidney Injury; Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Enzyme Inhibitors; Hypertension; Immunohistochemistry; Kidney; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley | 2011 |
A single beta-amino acid substitution to angiotensin II confers AT2 receptor selectivity and vascular function.
Topics: Amino Acid Substitution; Analysis of Variance; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Aorta; Blood Pressure; Cells, Cultured; Enzyme Inhibitors; HEK293 Cells; Humans; Imidazoles; Male; Mice; NG-Nitroarginine Methyl Ester; Protein Binding; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Vasodilation | 2011 |
Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Brain; Captopril; Cytokines; Heart; Hydralazine; Hypertension; In Vitro Techniques; Insulin; Kidney; Leptin; Male; Myocardial Contraction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Peptide Fragments; Perfusion; Proteinuria; Rats; Rats, Inbred SHR; Ventricular Function, Left | 2011 |
Contribution of renal purinergic receptors to renal vasoconstriction in angiotensin II-induced hypertensive rats.
Topics: Analysis of Variance; Angiotensin II; Animals; Arterioles; Blood Pressure; Blotting, Western; Glomerular Filtration Rate; Hemodynamics; Hypertension; Immunohistochemistry; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Receptors, Purinergic P2X1; Receptors, Purinergic P2Y1; Renal Circulation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasoconstriction | 2011 |
Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts.
Topics: Abietanes; Angiotensin II; Animals; Antioxidants; Cell Proliferation; Cells, Cultured; Drugs, Chinese Herbal; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Heart; Myocardium; Myofibroblasts; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Small Interfering; Salvia miltiorrhiza; Signal Transduction; Transfection | 2011 |
Relaxin ameliorates hypertension and increases nitric oxide metabolite excretion in angiotensin II but not N(ω)-nitro-L-arginine methyl ester hypertensive rats.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Relaxin | 2011 |
Exaggerated natriuresis during clamping of systemic NO supply in healthy young men.
Topics: Adult; Aldosterone; Angiotensin II; Enzyme Inhibitors; Glomerular Filtration Rate; Hemodynamics; Humans; Male; Models, Biological; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Renal Plasma Flow; Renin-Angiotensin System; Sodium Chloride; Young Adult | 2012 |
Modulation of the myogenic response in renal blood flow autoregulation by NO depends on endothelial nitric oxide synthase (eNOS), but not neuronal or inducible NOS.
Topics: Angiotensin II; Animals; Blood Pressure; Enzyme Inhibitors; Female; Homeostasis; Hypertension; Kidney; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Renal Circulation; Vascular Resistance; Vasoconstriction | 2011 |
17-Octadecynoic acid improves contractile response to angiotensin II by releasing vasocontrictor prostaglandins.
Topics: Angiotensin II; Animals; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Fatty Acids, Unsaturated; In Vitro Techniques; Male; Miconazole; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Norepinephrine; Potassium Chloride; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rabbits; Vasoconstriction | 2012 |
Early life stress enhances angiotensin II-mediated vasoconstriction by reduced endothelial nitric oxide buffering capacity.
Topics: Angiotensin II; Animals; Animals, Newborn; Aorta, Thoracic; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Male; Maternal Deprivation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Inbred WKY; Reactive Oxygen Species; Signal Transduction; Stress, Physiological; Vasoconstriction | 2011 |
Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Kidney Tubules, Proximal; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Sodium-Potassium-Exchanging ATPase; Tetrazoles | 2012 |
Protection of protease-activated receptor 2 mediated vasodilatation against angiotensin II-induced vascular dysfunction in mice.
Topics: Acetylcholine; Angiotensin II; Animals; Blotting, Western; Cyclooxygenase 1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Endothelium, Vascular; Gene Expression; In Vitro Techniques; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; Oligopeptides; Pyrazoles; Receptor, PAR-2; Reverse Transcriptase Polymerase Chain Reaction; Small-Conductance Calcium-Activated Potassium Channels; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2011 |
Adenosine A₁-receptor deficiency diminishes afferent arteriolar and blood pressure responses during nitric oxide inhibition and angiotensin II treatment.
Topics: Angiotensin II; Animals; Arginine; Arterioles; Blood Pressure; Gene Expression Regulation; Kidney; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptor, Adenosine A1 | 2011 |
Nitric oxide and angiotensin II regulate cardiovascular homeostasis and the arterial baroreflex control of heart rate in conscious lambs.
Topics: Angiotensin II; Animals; Arteries; Baroreflex; Consciousness; Female; Heart Rate; Homeostasis; Kidney; Male; Naphthyridines; NG-Nitroarginine Methyl Ester; Nitric Oxide; Regional Blood Flow; Sheep, Domestic; Vascular Resistance | 2012 |
Activation of the mineralocorticoid receptor increases striatin levels.
Topics: Aldosterone; Angiotensin II; Animals; Aorta; Calmodulin-Binding Proteins; Canrenoic Acid; Cells, Cultured; Diet, Sodium-Restricted; Endothelial Cells; Enzyme Inhibitors; Humans; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Myocardium; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Receptors, Mineralocorticoid | 2012 |
Angiotensin II augments renal vasoconstriction via AT1 receptors in L-NAME-induced hypertensive rats.
Topics: Angiotensin II; Animals; Hypertension; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Vasoconstriction | 2009 |
Angiotensin II pressor response in the L-NAME-induced hypertensive pithed rat: role of the AT1 receptor.
Topics: Angiotensin II; Animals; Blood Pressure; Hypertension; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1 | 2009 |
Haemodynamic responses to angiotensin II in conscious lambs: role of nitric oxide and prostaglandins.
Topics: Aging; Angiotensin II; Animals; Animals, Newborn; Blood Pressure; Cyclooxygenase Inhibitors; Female; Hemodynamics; Indomethacin; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prostaglandins; Renal Circulation; Sheep, Domestic; Vasoconstriction | 2012 |
Angiotensin-(1-7) suppresses the number and function of the circulating fibrocytes by upregulating endothelial nitric oxide synthase expression.
Topics: Angiotensin I; Angiotensin II; Apoptosis; Blood Cells; Cell Proliferation; Cells, Cultured; Collagen Type I; Fibroblasts; Humans; Hydroxyproline; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Up-Regulation | 2012 |
Total Flavonoids of Fructus Chorspondiatis inhibits collagen synthesis of cultured rat cardiac fibroblasts induced by angiotensin II: correlated with NO/cGMP signaling pathway.
Topics: Angiotensin II; Animals; Cells, Cultured; Collagen Type I; Collagen Type III; Cyclic GMP; Drugs, Chinese Herbal; Fibroblasts; Flavonoids; Hydroxyproline; Male; Myocardium; Myofibroblasts; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plant Extracts; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction | 2012 |
Role of specific T-type calcium channel blocker R(-) efonidipine in the regulation of renal medullary circulation.
Topics: Angiotensin II; Animals; Blood Flow Velocity; Calcium Channel Blockers; Calcium Channels, T-Type; Dihydropyridines; Disease Models, Animal; Drug Antagonism; Infusions, Intravenous; Ischemia; Kidney Medulla; Laser-Doppler Flowmetry; NG-Nitroarginine Methyl Ester; Nitrogen Dioxide; Nitrogen Oxides; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Renal Circulation; Vasoconstrictor Agents | 2012 |
An intact kidney slice model to investigate vasa recta properties and function in situ.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Antigens; Capillaries; Cell Survival; Endothelin-1; Enzyme Inhibitors; Immunohistochemistry; In Vitro Techniques; Indomethacin; Kidney Medulla; Male; Microscopy, Confocal; NG-Nitroarginine Methyl Ester; Norepinephrine; Pericytes; Proteoglycans; Rats; Rats, Sprague-Dawley; Signal Transduction; Sympathetic Nervous System; Vasoconstriction; Vasoconstrictor Agents | 2012 |
Effects of aging, TNF-α, and exercise training on angiotensin II-induced vasoconstriction of rat skeletal muscle arterioles.
Topics: Aging; Angiotensin II; Animals; Arterioles; Education; Endothelium, Vascular; Male; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Physical Conditioning, Animal; Rats; Rats, Inbred F344; Tumor Necrosis Factor-alpha; Vascular Resistance; Vasoconstriction | 2012 |
Iodinated contrast media differentially affect afferent and efferent arteriolar tone and reactivity in mice: a possible explanation for reduced glomerular filtration rate.
Topics: Analysis of Variance; Angiotensin II; Animals; Arterioles; Contrast Media; Cyclic N-Oxides; Dicarbethoxydihydrocollidine; Ethylamines; Fluoresceins; Glomerular Filtration Rate; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide; Spin Labels; Statistics, Nonparametric; Superoxides; Triiodobenzoic Acids; Vasoconstriction | 2012 |
AVE 0991, a non-peptide Mas-receptor agonist, facilitates penile erection.
Topics: Angiotensin II; Animals; Imidazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Penile Erection; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled | 2013 |
Sodium nitrite therapy rescues ischemia-induced neovascularization and blood flow recovery in hypertension.
Topics: Allopurinol; Angiotensin II; Animals; Arterial Pressure; Capillaries; Cyclic AMP; Cyclic GMP; Femoral Artery; Hindlimb; Hypertension; Indoles; Ischemia; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Regional Blood Flow; Sodium Nitrite; Xanthine Dehydrogenase | 2012 |
Mesangial cells cultured from pregnant rats display reduced reactivity to angiotensin II: the role of relaxin, nitric oxide and AT2 receptor.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Calcium Signaling; Cells, Cultured; Female; Imidazoles; Mesangial Cells; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pregnancy; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Receptors, Peptide; Relaxin | 2012 |
Evidence that kinin B2 receptor expression is upregulated by endothelial overexpression of B1 receptors.
Topics: Acetylcholinesterase; Angiotensin II; Animals; Aorta; Bradykinin; Bradykinin B1 Receptor Antagonists; Endothelium, Vascular; Gene Expression Regulation; In Vitro Techniques; Indomethacin; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Angiotensin, Type 1; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Up-Regulation; Vasodilation | 2013 |
Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Enzyme Inhibitors; Epoxide Hydrolases; Hypertension; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Transgenic; Thiobarbituric Acid Reactive Substances | 2013 |
Gynura procumbens causes vasodilation by inhibiting angiotensin II and enhancing bradykinin actions.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arterial Pressure; Asteraceae; Blood Pressure; Bradykinin; Cardiovascular Agents; Drug Synergism; Enzyme Inhibitors; In Vitro Techniques; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Plant Extracts; Rats; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents | 2013 |
Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation.
Topics: Angiotensin I; Angiotensin II; Animals; Bleeding Time; Blood Platelets; Bone Marrow Transplantation; Cyclic AMP; Cyclic GMP; Epoprostenol; Immunoblotting; Mice; Mice, 129 Strain; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Thrombosis; Time Factors | 2013 |
Nitric oxide in afferent arterioles after uninephrectomy depends on extracellular L-arginine.
Topics: Angiotensin II; Animals; Arginine; Arterioles; Blood Pressure; Body Weight; Enzyme Inhibitors; Extracellular Space; Glomerular Filtration Rate; Homeostasis; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Rats; Rats, Wistar; Renal Circulation; Vasoconstrictor Agents | 2013 |
Nitric oxide reduces Cl⁻ absorption in the mouse cortical collecting duct through an ENaC-dependent mechanism.
Topics: Absorption; Aldosterone; Amiloride; Angiotensin II; Animals; Anion Transport Proteins; Chloride-Bicarbonate Antiporters; Chlorides; Epithelial Sodium Channels; Female; In Vitro Techniques; Kidney Tubules, Collecting; Male; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Sodium; Sulfate Transporters | 2013 |
Exercise reduces angiotensin II responses in rat femoral veins.
Topics: Adaptation, Physiological; Angiotensin II; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Endothelin-1; Femoral Vein; Gene Expression; In Vitro Techniques; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; Peptides, Cyclic; Physical Conditioning, Animal; Physical Exertion; Piperidines; Rats; Vasoconstriction | 2013 |
The absence of intrarenal ACE protects against hypertension.
Topics: Angiotensin II; Animals; Hypertension; Kidney; Liver; Loop of Henle; Male; Mice; NG-Nitroarginine Methyl Ester; Peptidyl-Dipeptidase A; Protein Serine-Threonine Kinases; Receptors, Drug; Renin-Angiotensin System; Sodium; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 3; Symporters; Water | 2013 |
Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Bradykinin; Calcium; Kinins; Macrophages; Mice, Inbred C57BL; Mice, Transgenic; Monocytes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Receptor, Angiotensin, Type 2; Superoxides; Vascular Cell Adhesion Molecule-1 | 2015 |
Role of angiotensin AT2 receptors and nitric oxide in the cardiopulmonary baroreflex control of renal sympathetic nerve activity in rats.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Baroreflex; Blood Pressure; Enzyme Inhibitors; Imidazoles; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oligopeptides; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Sympathetic Nervous System | 2013 |
An anatomically unbiased approach for analysis of renal BOLD magnetic resonance images.
Topics: Acetylcholine; Angiotensin II; Animals; Hypoxia; Kidney; Kidney Cortex; Kidney Medulla; Magnetic Resonance Imaging; Male; NG-Nitroarginine Methyl Ester; Oxygen; Rats; Rats, Inbred F344 | 2013 |
Renal angiotensin-converting enzyme is essential for the hypertension induced by nitric oxide synthesis inhibition.
Topics: Angiotensin II; Animals; Blood Pressure; Glomerular Filtration Rate; Hypertension; Kidney; Male; Mice; Mice, Inbred C57BL; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Renin; Symporters | 2014 |
Upregulation of ERK1/2-eNOS via AT2 receptors decreases the contractile response to angiotensin II in resistance mesenteric arteries from obese rats.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Blotting, Western; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Male; Mesenteric Arteries; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Obesity; Phosphorylation; Pyridines; Rats, Wistar; Receptor, Angiotensin, Type 2; Up-Regulation; Vasoconstriction; Vasoconstrictor Agents | 2014 |
Elevated pressure causes endothelial dysfunction in mouse carotid arteries by increasing local angiotensin signaling.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Carotid Arteries; Endothelium, Vascular; Hydrazines; Hypertension; Indoles; Losartan; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Reactive Oxygen Species; Signal Transduction; Tetrazoles; Valine; Valsartan; Vasodilation | 2015 |
Knockdown of angiopoietin like-2 protects against angiotensin II-induced cerebral endothelial dysfunction in mice.
Topics: Acetophenones; Acetylcholine; Angiopoietin-Like Protein 2; Angiopoietin-like Proteins; Angiopoietins; Angiotensin II; Animals; Cerebral Arteries; Endothelium, Vascular; Gene Deletion; Glycoproteins; Hydrogen Peroxide; Indomethacin; Mice; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Vasoconstriction | 2015 |
PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension.
Topics: Amiloride; Angiotensin II; Animals; Arteries; Blood Pressure; Blood Pressure Determination; Disease Models, Animal; Epithelial Sodium Channels; Female; Hypertension; Kidney; Male; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Proprotein Convertase 9; Proprotein Convertases; Serine Endopeptidases; Sodium; Sodium Chloride, Dietary | 2015 |
Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-L-arginine methyl ester induced hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Captopril; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Gene Expression Regulation; Hypertension, Renal; Kidney Cortex; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Random Allocation; Rats, Wistar; Renin; RNA, Messenger | 2015 |
Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Blood Pressure; Chemokine CCL2; Disease Models, Animal; Enzyme Inhibitors; Kidney; Macrophages; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Osteopontin; Rats; Renal Insufficiency, Chronic; Renin-Angiotensin System; RNA, Messenger; Time Factors; Transforming Growth Factor beta1 | 2015 |
Renal Effects of Cyclooxygenase Inhibition When Nitric Oxide Synthesis Is Reduced and Angiotensin II Levels Are Enhanced.
Topics: Angiotensin II; Animals; Blood Pressure; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dogs; Female; Glomerular Filtration Rate; Infusions, Intravenous; Male; Meclofenamic Acid; Models, Animal; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renal Artery; Sulfonamides; Vasoconstriction | 2015 |
Losartan and Sodium Nitroprusside Effectively Protect against Renal Impairments after Ischemia and Reperfusion in Rats.
Topics: Adenosine Triphosphatases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arginine; Captopril; Ischemia; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroprusside; Peptides, Cyclic; Rats, Wistar; Renal Insufficiency; Reperfusion; Reperfusion Injury | 2015 |
Microglia participate in neurogenic regulation of hypertension.
Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Diphtheria Toxin; Disease Models, Animal; Hypertension; Infusions, Intraventricular; Mice; Mice, Inbred C57BL; Microglia; NG-Nitroarginine Methyl Ester; Sympathetic Nervous System | 2015 |
Salt Sensitivity in Response to Renal Injury Requires Renal Angiotensin-Converting Enzyme.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Disease Models, Animal; Hypertension; Kidney; Mice; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Peptidyl-Dipeptidase A; Sodium Chloride, Dietary | 2015 |
Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiovascular System; Caveolin 1; Cyclic GMP; Eplerenone; Heart Injuries; Male; Mice; Mineralocorticoid Receptor Antagonists; Models, Molecular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nucleic Acid Conformation; Receptors, Mineralocorticoid; Renin-Angiotensin System; Signal Transduction; Spironolactone; Vasoconstriction; Vasodilation | 2015 |
Myeloid Suppressor Cells Accumulate and Regulate Blood Pressure in Hypertension.
Topics: Adoptive Transfer; Angiotensin II; Animals; Antigens, Ly; Blood Pressure; CD11b Antigen; Cells, Cultured; Disease Models, Animal; Hydrogen Peroxide; Hypertension; Immune Tolerance; Inflammation Mediators; Lymphocyte Activation; Male; Membrane Glycoproteins; Mice, Inbred C57BL; Mice, Knockout; Myeloid Cells; NADPH Oxidase 2; NADPH Oxidases; Nephritis; NG-Nitroarginine Methyl Ester; Signal Transduction; Sodium, Dietary; T-Lymphocytes; Time Factors | 2015 |
Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Diminazene; Heart Rate; Hypertension, Renovascular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled | 2016 |
Nebivolol Ameliorates Cisplatin-Induced Nephrotoxicity in Rats.
Topics: Adrenergic beta-1 Receptor Agonists; Angiotensin II; Animals; Antineoplastic Agents; Cisplatin; Creatinine; Endothelin-1; Kidney; Kidney Function Tests; Male; Nebivolol; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Urea | 2016 |
Experimental hypertension increases spontaneous intracerebral hemorrhages in a mouse model of cerebral amyloidosis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II; Animals; Blood Pressure; Brain; Cerebral Amyloid Angiopathy; Female; Humans; Hypertension; Intracranial Hemorrhage, Hypertensive; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Risk Factors; Stroke | 2016 |
Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; DNA, Mitochondrial; Electron Transport Complex I; Electron Transport Complex II; Enzyme Inhibitors; Gene Expression; Heart; Heart Failure; Hydrogen Peroxide; Mice; Mitochondria, Heart; Myocardium; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Protein Precursors; Pyruvate Dehydrogenase Complex; Reverse Transcriptase Polymerase Chain Reaction; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Vasoconstrictor Agents | 2016 |
Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis.
Topics: Angiotensin II; Animals; Apoptosis; B-Lymphocytes; Cardiomyopathies; Collagen; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Hypertrophy, Left Ventricular; Immunoglobulin G; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, SCID; Myocardium; NG-Nitroarginine Methyl Ester; Phenotype; Sialic Acid Binding Ig-like Lectin 2; Signal Transduction; Sodium Chloride; Stroke Volume; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2016 |
The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cytokines; Enzyme Inhibitors; Gastric Mucosa; Imidazoles; Indomethacin; Interleukin-1beta; Lisinopril; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Stomach Ulcer; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2016 |
Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Antioxidants; Aorta; Apolipoproteins E; Apoptosis; Atherosclerosis; Cell Survival; Cells, Cultured; Endothelial Cells; Humans; Hydrogen Peroxide; Male; Membrane Potential, Mitochondrial; Mice; Mice, Knockout; Microscopy, Confocal; Mitochondria; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Oxygen Consumption; Phosphorylation; RNA Interference; RNA, Small Interfering; Sirtuin 3; Umbelliferones | 2016 |
Simultaneous exposure to nitric oxide inhibition and angiotensin II overload: is it a murine model of mitochondrial dysfunction in nonischemic heart failure?
Topics: Angiotensin II; Animals; Disease Models, Animal; Heart Failure; Mice; Mitochondria; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress | 2016 |
Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia.
Topics: Angiotensin II; Angiotensins; Animals; Blood Pressure; Disease Models, Animal; Female; Humans; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy, Animal; Signal Transduction; Sildenafil Citrate; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-1 | 2016 |
The role of brain angiotensin II (type 2) receptors and nitric oxide in the renal sympathoinhibitory response to acute volume expansion in conscious rats.
Topics: Administration, Intravenous; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Arterial Pressure; Body Fluids; Brain; Enzyme Inhibitors; Heart Rate; Imidazoles; Infusions, Intraventricular; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oligopeptides; Pyridines; Rats; Receptor, Angiotensin, Type 2; Sodium Chloride; Sympathetic Nervous System | 2017 |
Renal tubular angiotensin converting enzyme is responsible for nitro-L-arginine methyl ester (L-NAME)-induced salt sensitivity.
Topics: Angiotensin II; Animals; Arterial Pressure; Disease Models, Animal; Epithelial Sodium Channels; Gene Expression Regulation, Enzymologic; Hypertension; Kidney Tubules; Liver; Mice, Transgenic; Natriuresis; NG-Nitroarginine Methyl Ester; Peptidyl-Dipeptidase A; Renal Elimination; Renin-Angiotensin System; Sodium Chloride, Dietary; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 3; Time Factors | 2017 |
Endothelin Receptor Down-Regulation Mediated Ligand Regulation Mechanisms Protect Against Cellular Hypoxia Injury in Rat Vascular Endothelial Cells.
Topics: Angiotensin II; Animals; Cell Hypoxia; Coculture Techniques; Down-Regulation; Endothelial Cells; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Interferon-gamma; Interleukin-6; Kidney; Ligands; Male; Models, Biological; NF-kappa B; NG-Nitroarginine Methyl Ester; Protective Agents; Rats, Sprague-Dawley; Receptor, Endothelin A; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Smad3 Protein; Transfection; Tumor Necrosis Factor-alpha | 2016 |
Prostanoids counterbalance the synergism between endothelin-1 and angiotensin II in mesenteric veins of trained rats.
Topics: Angiotensin II; Animals; Endothelin-1; Femoral Vein; Gene Expression Regulation; Imidazoles; Indomethacin; Mesenteric Veins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Culture Techniques; Physical Conditioning, Animal; Prostaglandins; Pyridines; Rats; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Vasoconstriction | 2017 |
Myoglobin facilitates angiotensin II-induced constriction of renal afferent arterioles.
Topics: Angiotensin II; Animals; Antioxidants; Arterioles; Calcium Signaling; Cyclic N-Oxides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kidney; Male; Mice, Inbred C57BL; Microscopy, Video; Myoglobin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rhabdomyolysis; Spin Labels; Superoxides; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 2017 |
Endothelial Cells Inhibit the Angiotensin II Induced Phenotypic Modulation of Rat Vascular Adventitial Fibroblasts.
Topics: Actins; Adventitia; Angiotensin II; Animals; Aorta, Thoracic; Arginine; Cells, Cultured; Coculture Techniques; Collagen Type I; Cyclic GMP; Endothelial Cells; Fibroblasts; Homocysteine; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Signal Transduction | 2017 |
Insulin-like growth factor 1 deficiency exacerbates hypertension-induced cerebral microhemorrhages in mice, mimicking the aging phenotype.
Topics: Aging; Angiotensin II; Animals; Cerebral Hemorrhage; Disease Models, Animal; Extracellular Matrix; Gait; Hypertension; Infusion Pumps, Implantable; Insulin-Like Growth Factor I; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Oxidative Stress; Phenotype; Psychomotor Performance | 2017 |
Treatment with Standard and Low Dose of Conjugated Equine Estrogen Differentially Modulates Estrogen Receptor Expression and Response to Angiotensin II in Mesenteric Venular Bed of Surgically Postmenopausal Hypertensive Rats.
Topics: Angiotensin II; Animals; Blood Pressure; Enzyme Inhibitors; Estrogens, Conjugated (USP); Female; Horses; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Ovariectomy; Postmenopause; Rats, Inbred SHR; Receptor, Angiotensin, Type 2; Receptors, Estrogen; Splanchnic Circulation | 2017 |
Rho-kinase and the nitric oxide pathway modulate basilar arterial reactivity to acetylcholine and angiotensin II in streptozotocin-induced diabetic mice.
Topics: Acetylcholine; Amides; Angiotensin II; Animals; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Male; Mice; Mice, Inbred ICR; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyridines; rho-Associated Kinases; Streptozocin; Time Factors | 2017 |
Differential responses of mesenteric arterial bed to vasoactive substances in L-NAME-induced preeclampsia: Role of oxidative stress and endothelial dysfunction.
Topics: Acetylcholine; Angiotensin II; Animals; Arginine; Blood Pressure; Enzyme Inhibitors; Female; Fetal Growth Retardation; Glutathione Peroxidase; Hypertension; Malondialdehyde; Mesentery; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroglycerin; Oxidative Stress; Phenylephrine; Placenta; Pre-Eclampsia; Pregnancy; Protein Carbonylation; Rats; Superoxide Dismutase; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2018 |
Angiotensin-(1-7) in Paraventricular Nucleus Contributes to the Enhanced Cardiac Sympathetic Afferent Reflex and Sympathetic Activity in Chronic Heart Failure Rats.
Topics: Acetophenones; Angiotensin I; Angiotensin II; Animals; Arterial Pressure; Capsaicin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic N-Oxides; Heart Failure; Hemodynamics; Kidney; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Sprague-Dawley; Signal Transduction; Spin Labels; Superoxides; Sympathetic Nervous System | 2017 |
Glomerular and tubular effects of nitric oxide (NO) are regulated by angiotensin II (Ang II) in an age-dependent manner through activation of both angiotensin receptors (AT1Rs and AT2Rs) in conscious lambs.
Topics: Aging; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Female; Male; Nephrons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptors, Angiotensin; Sheep; Urodynamics; Wakefulness; Water-Electrolyte Balance | 2018 |
Icariin improves acute kidney injury and proteinuria in a rat model of pregnancy‑induced hypertension.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Blood Pressure; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Down-Regulation; Female; Flavonoids; Gestational Age; Hypertension, Pregnancy-Induced; Kidney; Membrane Proteins; NG-Nitroarginine Methyl Ester; Pregnancy; Proteinuria; Rats; Rats, Wistar; Renin-Angiotensin System; Reproduction; Up-Regulation | 2017 |
Nitric oxide production by glomerular podocytes.
Topics: Angiotensin II; Animals; Calcium Signaling; Glomerular Filtration Barrier; Hydrogen Peroxide; Hypertension; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Podocytes; Rats, Inbred Dahl; Sodium Chloride, Dietary | 2018 |
Effect of Angiotensin II and ACTH on Adrenal Blood Flow in the Male Rat Adrenal Gland In Vivo.
Topics: 8,11,14-Eicosatrienoic Acid; Adrenal Glands; Adrenocorticotropic Hormone; Angiotensin II; Animals; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Eicosanoids; Endothelium, Vascular; Enzyme Inhibitors; Indomethacin; Injections, Intravenous; Male; Miconazole; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Receptors, Corticotropin; Regional Blood Flow; Signal Transduction | 2018 |
Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide.
Topics: Angiotensin II; Animals; Biomarkers; C-Peptide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enzyme Inhibitors; Islets of Langerhans; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2018 |
Developmental programming of vascular dysfunction by prenatal and postnatal zinc deficiency in male and female rats.
Topics: Acetylcholine; Angiotensin II; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Aorta, Thoracic; Calcium; Female; Lactation; Male; Malnutrition; Maternal Nutritional Physiological Phenomena; Micronutrients; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Oxidants; Oxidative Stress; Pregnancy; Pregnancy, Animal; Rats; Rats, Wistar; Systole; Vascular Diseases; Vasoconstrictor Agents; Zinc | 2018 |
Angiotensin IV improves subnormothermic machine perfusion preservation of rat liver graft.
Topics: Angiotensin II; Animals; Apoptosis; Disaccharides; Electrolytes; Endothelium, Vascular; Glutamates; Glutathione; Histidine; Isotonic Solutions; Liver; Male; Mannitol; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Organ Preservation Solutions; Oxidative Stress; Perfusion; Rats; Rats, Sprague-Dawley; Transplants | 2018 |
Hemostatic effect of acylated ghrelin in control and sleeve gastrectomy-induced rats: mechanisms of action.
Topics: Acylation; Angiotensin II; Animals; Aorta; Blood Coagulation; Drug Administration Schedule; Endothelial Cells; Fibrinogen; Gastrectomy; Gene Expression; Ghrelin; Hemostatics; Injections, Subcutaneous; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Oligopeptides; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Receptors, Ghrelin; Thromboxane B2; von Willebrand Factor | 2020 |
Connexin37-Dependent Mechanisms Selectively Contribute to Modulate Angiotensin II -Mediated Hypertension.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Connexins; Disease Models, Animal; Endothelial Cells; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gap Junction alpha-4 Protein; Hypertension; Male; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Myosin Light Chains; NG-Nitroarginine Methyl Ester; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 2; Renin; Vasoconstrictor Agents | 2019 |
The protective effects of polysaccharide extract from Xin-Ji-Er-Kang formula on Ang II-induced HUVECs injury, L-NAME-induced hypertension and cardiovascular remodeling in mice.
Topics: Angiotensin II; Animals; Aorta; Arginine; Blood Pressure; Cytokines; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Endothelial Cells; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Inflammation; Male; Malondialdehyde; Mice; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phytotherapy; Superoxide Dismutase; Vascular Remodeling | 2019 |
Protective effect of apelin preconditioning in a rat model of hepatic ischemia reperfusion injury; possible interaction between the apelin/APJ system, Ang II/AT1R system and eNOS.
Topics: Alanine Transaminase; Angiotensin II; Animals; Apelin; Aspartate Aminotransferases; Caspase 3; Disease Models, Animal; Gene Expression; Ischemic Preconditioning; Liver; Male; Malondialdehyde; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Reperfusion Injury | 2019 |
Exercise training attenuates angiotensin II-induced vasoconstriction in the aorta of normotensive but not hypertensive rats.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Hypertension; Hypertension, Renovascular; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Physical Conditioning, Animal; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Vasoconstriction | 2020 |
Aortic remodeling is modest and sex-independent in mice when hypertension is superimposed on aging.
Topics: Aging; Angiotensin II; Animals; Aorta; Aorta, Abdominal; Aorta, Thoracic; Female; Hemodynamics; Hypertension; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Phenotype; Sodium Chloride, Dietary | 2020 |
Angiotensin converting enzyme inhibitor potentiates the hypoglycaemic effect of NG-nitro-L-arginine methyl ester (L-NAME) in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Endothelin-1; Enzyme Inhibitors; Hypertension; Hypoglycemic Agents; Insulins; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Prostaglandins I; Ramipril; Rats; Rats, Wistar | 2022 |
1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Epoxide Hydrolases; Hypertension; Male; NG-Nitroarginine Methyl Ester; Phenylurea Compounds; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1 | 2020 |
The Possible Regulatory Mechanisms of Aqueous, Ethyl Acetate and NHexane Fractions of the Ribes khorassanicum Extract on Acute Hypertension in Rats.
Topics: Acetates; Acute Disease; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular System; Disease Models, Animal; Hexanes; Hypertension; Losartan; Male; NG-Nitroarginine Methyl Ester; Plant Extracts; Rats; Rats, Wistar; Ribes; Signal Transduction; Water | 2021 |
Role of soluble guanylyl cyclase in renal afferent and efferent arterioles.
Topics: Angiotensin II; Animals; Arterioles; Cyclic Nucleotide Phosphodiesterases, Type 5; Gene Expression Regulation, Enzymologic; Kidney; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphodiesterase 5 Inhibitors; Soluble Guanylyl Cyclase | 2021 |
Autophagy contributes to angiotensin II induced dysfunction of HUVECs.
Topics: Acetophenones; Adenine; Angiotensin II; Animals; Autophagosomes; Autophagy; Autophagy-Related Proteins; Benzimidazoles; Biphenyl Compounds; Decanoic Acids; Human Umbilical Vein Endothelial Cells; Humans; Hydroxy Acids; Models, Biological; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Signal Transduction; Sirolimus; Tetrazoles; Time Factors | 2021 |
CRIP1 expression in monocytes related to hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Carrier Proteins; Cell Differentiation; Cohort Studies; Disease Models, Animal; Humans; Hypertension; Macrophages; Male; Monocytes; NG-Nitroarginine Methyl Ester; Spleen; Transcriptome | 2021 |
Clitoria ternatea L. extract prevents kidney damage by suppressing the Ang II/Nox4/oxidative stress cascade in l-NAME-induced hypertension model of rats.
Topics: Angiotensin II; Animals; Clitoria; Hypertension; Kidney; NADPH Oxidase 4; NG-Nitroarginine Methyl Ester; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley | 2021 |
Roxadustat prevents Ang II hypertension by targeting angiotensin receptors and eNOS.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Cells, Cultured; Electrolytes; Endothelial Cells; Glycine; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Isoquinolines; Kidney Glomerulus; Male; Mice; Myocytes, Smooth Muscle; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Proteinuria; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Thiobarbituric Acid Reactive Substances; Urine; Vascular Remodeling | 2021 |
Restoration of Mitochondrial Function Is Essential in the Endothelium-Dependent Vasodilation Induced by Acacetin in Hypertensive Rats.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Blood Pressure; Endothelium, Vascular; Flavones; Hypertension; Hypotension; Mitochondria; Mitochondrial Permeability Transition Pore; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptidyl-Prolyl Isomerase F; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Vasodilation | 2022 |